[go: up one dir, main page]

TW200808817A - Product and process - Google Patents

Product and process Download PDF

Info

Publication number
TW200808817A
TW200808817A TW096114187A TW96114187A TW200808817A TW 200808817 A TW200808817 A TW 200808817A TW 096114187 A TW096114187 A TW 096114187A TW 96114187 A TW96114187 A TW 96114187A TW 200808817 A TW200808817 A TW 200808817A
Authority
TW
Taiwan
Prior art keywords
product
feed material
solvent
feed
ethanol
Prior art date
Application number
TW096114187A
Other languages
Chinese (zh)
Inventor
David Stevenson
Dawn Scott
Owen John Catchpole
Andrew Mackenzie
Mikhail Vyssotski
Vasily Svetashev
Tina Fenton
Jason Murney
Original Assignee
David Stevenson
Dawn Scott
Owen John Catchpole
Andrew Mackenzie
Mikhail Vyssotski
Vasily Svetashev
Tina Fenton
Jason Murney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David Stevenson, Dawn Scott, Owen John Catchpole, Andrew Mackenzie, Mikhail Vyssotski, Vasily Svetashev, Tina Fenton, Jason Murney filed Critical David Stevenson
Publication of TW200808817A publication Critical patent/TW200808817A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B7/00Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
    • C11B7/0008Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents
    • C11B7/005Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents in solvents used at superatmospheric pressures
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification
    • A23L5/23Removal of unwanted matter, e.g. deodorisation or detoxification by extraction with solvents
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B7/00Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
    • C11B7/0008Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents
    • C11B7/0025Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents in solvents containing oxygen in their molecule
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Fodder In General (AREA)

Abstract

The present application relates to processes for fractionating a feed material into soluble and insoluble components, by contacting a feed material and a solvent and subsequently separating the solvent containing the soluble components from the insoluble components, wherein the feed material comprises one or more of: at least 1% w/w phosphatidyl serine, at least 1% w/w sphingomyelin, at least 1% w/w cardiolipin, or at least 0.3% w/w gangliosides, and wherein the solvent comprises one or more C1-C3 monohydric alcohols and water (wherein the water content of the one or more alcohols is 0 to 40% v/v).

Description

200808817 九、發明說明: 【發明所屬之技術領域】 本發明係關於分餾方法。更詳言之’本發明係關於一種 分餾含有麟脂(例如包括填脂醯綠胺酸、心填脂或神經鞘、 磷脂)、神經結醣脂或其組合之饋入材料之方法。 【先前技術】 填脂為所有生物膜之主要成份,且包括磷酸甘油醋(例 如,磷脂醯膽鹼(PC)、磷脂醯乙醇胺(PE)、磷脂醯肌醇. (PI)、心磷脂(CL)及磷脂醯絲胺酸(PS))及鞘脂(諸如神經勒 磷脂(SM))。 神經結醣脂(GS)為細胞質膜中調節細胞信號轉導事件之 成份。該等成份涉及在免疫、大腦功能及神經退化性病症 中尤為重要。 磷脂與躺脂涉及在導致(例如)細胞生長、細胞分化、細 胞增殖及漸進式細胞死亡(細胞凋亡)之細胞信號轉導事件 中。 合理含量之此等成份可於奶、大豆製品、蛋、動物組 織、海洋動物、植物、微生物及其他來源中發現。熟知之 來源為已知含有有用量之神經鞘磷脂、腦甘脂、神經結醣 脂、填脂醯絲胺酸及其他構脂之牛乳脂球膜(mfgm) (Jensen 2002)。 磷脂及鞘脂已涉及在具有許多健康益處中,包括大腦健 康、運動營養、皮膚健康、濕疹治療、抗感染、傷口癒 合、腸道微生物菌群改進、抗癌活性、減輕關節炎、改善 120457.doc 200808817 心血管健康及治療代謝症候群。 先前已將醇-水混合物用於分離或富集磷脂PC、ΡΈ及PI 及/或用於神經結醣脂。Wu & Wang (2004)描述使用乙醇 水溶液及不同溫度處理來分餾大豆卵磷脂。將條件最優化 以產生高PC及高PI部分。發現較高油(中性脂質)含量顯著 提高PC部分之產率。但顯著降低PI部分之產率、純度及回 收率。將卵磷脂-乙醇混合物攪拌1小時繼而離心以形成富 含PC之部分(上清液)及富含PI之部分(沉澱)。在移除溶劑 之後,以丙酮處理PI部分以移除中性脂質。在溶劑與卵磷 脂比為5:1時以84%、89%、95%及99%之濃度使用乙醇水 溶液。發現卵磷脂-乙醇混合物之最優水分含量為24%,該 含量係藉由使用5:1之95%乙醇-卵磷脂比達成。PC部分之 產率、純度及回收率隨著溫度升高而增加,在4(TC下獲得 最大純度。最優溶劑-樣品比為6:1 (在PC產率及回收率方 面)或10:1(對於PI而言)。當分餾兩次時達成PC之最大純 度,但PI部分之純度隨分餾次數增加而降低。最優分餾要 求40%之饋料樣品油含量。使用較高溫度分餾繼而在分餾 之後施加較低溫度可增加PC部分之純度,但PC部分之產 率及回收率低。未揭示獲得富含PS之部分、富含SM之部 分、富含CL之部分或富含GS之部分之方法。 用於獲得高PS部分之傳統方法不是富集含PS之混合物, 而是使用磷脂酶D、絲胺酸及PC或含PC之磷脂混合物(US 5,700,668 A、KR2003086128 A 及 JP 2079990 A)。此處使 用磷脂酶D酶將PC轉化為PS。 120457.doc 200808817 在JP 2002241385 A中,將磷脂混合物溶於醇中,繼而 添加金屬鹽以沉澱PS,而JP 3047192 A及JP 2805522 B2揭 示應用使用含飽和烴、醇及醚之混合水性溶劑之離心分溶 層析來分離PE、PC及SM。200808817 IX. DESCRIPTION OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to a fractionation method. More particularly, the present invention relates to a method of fractionating a feed material comprising a linal (e.g., a fat-filled glutamate, a heart-filled or sphingolipid, a phospholipid), a nerveolipid, or a combination thereof. [Prior Art] Filling is the main component of all biofilms, and includes glycerol phosphate (for example, phospholipid choline (PC), phospholipid oxime ethanol (PE), phospholipid creatinine (PI), cardiolipin (CL) And phospholipids serine (PS) and sphingolipids (such as neurolemin (SM)). Ganolysin (GS) is a component of the cytoplasmic membrane that regulates cellular signaling events. These components are particularly important in immune, brain function and neurodegenerative disorders. Phospholipids and lyophiles are involved in cellular signal transduction events leading to, for example, cell growth, cell differentiation, cell proliferation, and progressive cell death (apoptosis). A reasonable amount of such ingredients can be found in milk, soy products, eggs, animal tissues, marine animals, plants, microorganisms and other sources. A well-known source is a bovine milk globule membrane (mfgm) known to contain a useful amount of sphingomyelin, brain glycol, ribose, linsenoic acid and other structures (Jensen 2002). Phospholipids and sphingolipids have been involved in many health benefits including brain health, sports nutrition, skin health, eczema treatment, anti-infection, wound healing, intestinal microflora improvement, anti-cancer activity, arthritis reduction, improvement 120457 .doc 200808817 Cardiovascular Health and Treatment of Metabolic Syndrome. The alcohol-water mixture has previously been used to separate or enrich phospholipid PC, sputum and PI and/or for neuroglycolipids. Wu & Wang (2004) describes the use of aqueous ethanol solutions and different temperature treatments to fractionate soy lecithin. The conditions are optimized to produce high PC and high PI fractions. The higher oil (neutral lipid) content was found to significantly increase the yield of the PC fraction. However, the yield, purity and recovery of the PI fraction are significantly reduced. The lecithin-ethanol mixture was stirred for 1 hour and then centrifuged to form a PC-rich fraction (supernatant) and a PI-rich fraction (precipitate). After removing the solvent, the PI fraction was treated with acetone to remove neutral lipids. The ethanol aqueous solution was used at a concentration of 84%, 89%, 95%, and 99% at a solvent to egg phospholipid ratio of 5:1. The lecithin-ethanol mixture was found to have an optimum moisture content of 24%, which was achieved by using a 5:1 95% ethanol-lecithin ratio. The yield, purity and recovery of the PC fraction increased with increasing temperature and maximum purity was obtained at 4 (TC). The optimum solvent-to-sample ratio was 6:1 (in terms of PC yield and recovery) or 10: 1 (for PI). The maximum purity of PC is achieved when fractionated twice, but the purity of the PI fraction decreases as the number of fractionation increases. The optimal fractionation requires 40% of the feed sample oil content. Higher temperature fractionation is used. Applying a lower temperature after fractionation increases the purity of the PC fraction, but the yield and recovery of the PC fraction is low. No PS-rich fraction, SM-rich fraction, CL-rich fraction or GS-rich Part of the method. The traditional method for obtaining high PS fractions is not to enrich the mixture containing PS, but to use phospholipase D, serine and PC or PC-containing phospholipid mixtures (US 5,700,668 A, KR2003086128 A and JP 2079990 A). The phospholipase D enzyme is used herein to convert PC to PS. 120457.doc 200808817 In JP 2002241385 A, a phospholipid mixture is dissolved in an alcohol, followed by a metal salt to precipitate PS, and JP 3047192 A and JP 2805522 B2 disclose Application of saturated hydrocarbons, alcohols and Mixing the aqueous solvent centrifugation partitioned chromatography separation of PE, PC and SM.

JP 8322472 A揭示一種自植物(大豆)卵碟脂濃縮酸性脂 質之方法。以含有小於或等於15%水且較佳小於或等於 1 0%水之低級醇在30°C以上且較佳在35 —8〇乞下處理植物來 源之印磷脂(適當地為含有至少40%磷脂之大豆卵磷脂)。 接著移除低級醇部分。以重量計磷脂與低級醇之比率較佳 大於15。另外,較佳將處理重複3-5次,其中各處理均使 用以重量計大於1之磷脂與低級醇比。所得之酸性磷脂濃 縮物較佳含有60%以上之PI及磷脂酸(PA)。JP 95 15 1260 A 及US 5,833,858 A描述一種更詳細之方法,其中第一步驟 包含以含85%至100%低級醇之溶劑處理植物來源之卵磷 脂,接著除去含該低級醇之溶劑部分以得到磷脂混合物, 且第二步驟包含以含75%或更少乙醇之水溶液處理該磷脂 混合物。在第二步驟中有效地移除第一步驟中獲得之磷脂 混合物中所含之水溶性成份。因此,含高濃度酸性磷脂PI 及PA之脂質混合物可相對易於自植物來源之卵磷脂獲得。 然而,未揭示濃縮PS、SM、CL或GS之方法。 JP 1026548 5 A描述使用含氨乙醇自卵磷脂製備高度濃 縮之PA與PI混合物以及PE與PC混合物。另一更精細之方 法揭示於US 5,2 14,171 A中,該方法係用於藉由使用醇溶 劑(藉由適當調節溶劑之酸性來控制其中PC、PE及PA之溶 I20457.doc 200808817 解度,將pH值調節至8以上以溶解PC及PE且調節至5以下 以溶解PA)進行萃取步驟而將磷脂混合物分餾成兩個或兩 個以上富含PC、PE、PI及PA中之一或多者之部分。PI實 質上不可溶於該方法中所用之溶劑中且戸此主要在萃取殘 留物中回收。影響待分餾之磷脂混合物成份之溶解度的其 他參數為醇溶劑之水含量、溫度及調節pH值之鹼及酸之選 擇。為進一步分離富含PC及PE之部分,使用二價金屬‘鹽 或三價金屬鹽溶液。未揭示濃縮PS、SM、CL或GS之方 法。 為產生富含SM之部分,將含5-15% SM之混合物溶解於 醇(視情況含有水)中且濃縮溶液,繼而以脂族烴萃取且以 脂族酮沉澱(WO 2000/45828 A1)。稍微類似之方法揭示於 WO 94/18289 A1中,其中將磷脂與低級脂族醇(甲醇、乙 醇、丙醇、丁醇)及基本上非極性溶劑(烴或氯仿)混合,收. 集非極性相且藉由添加酮或乙酸曱酯或乙酸乙酯來沉澱 SM。此等方法具有使用多種溶劑達成所需分離之缺點。 在小規模實驗室實務中,丁醇-水-二異丙醚分溶法為製 備富含GS之部分之有效方式(Ladish & Gillard 1985)。此 方法可應用於原生質、細胞或動物組織之總脂質萃取物。 在由二異丙醚、1-丁醇及50M NaCl水溶液(6/4/5,體稽/體 積/體積)組成之3成份溶劑系統中進行經乾燥總脂質萃取物 之分溶。神經結醣脂接近定量地分溶至下層水相中且其他 脂質分溶至由此三種溶劑之混合物產生之上層有機相中。 接著藉由凝膠過濾去除含神經結醣脂之水相中之鹽及其他 120457.doc -10- 200808817 低分子量雜質。 神、、二、、。醣月曰之商業規模製造通常涉及在鹼性條件下加熱 含神經結醣m如白料奶或乳清蛋白濃縮物(例JP 8322472 A discloses a method for concentrating acidic lipids from plant (soybean) egg fat. Treating plant-derived phospholipids (suitably at least 40%) at a temperature above 30 ° C and preferably at 35-8 ° C with a lower alcohol containing less than or equal to 15% water and preferably less than or equal to 10% water Soy lecithin of phospholipids). The lower alcohol fraction is then removed. The ratio of phospholipid to lower alcohol by weight is preferably greater than 15. Further, it is preferred to repeat the treatment 3-5 times, wherein each treatment results in a ratio of phospholipid to lower alcohol of more than 1 by weight. The resulting acidic phospholipid concentrate preferably contains 60% or more of PI and phosphatidic acid (PA). A more detailed method is described in JP 95 15 1260 A and US Pat. No. 5,833,858 A, wherein the first step comprises treating the plant-derived lecithin with a solvent comprising 85% to 100% lower alcohol, followed by removing the solvent portion containing the lower alcohol to obtain A phospholipid mixture, and the second step comprises treating the phospholipid mixture with an aqueous solution containing 75% or less ethanol. The water-soluble component contained in the phospholipid mixture obtained in the first step is effectively removed in the second step. Therefore, a lipid mixture containing a high concentration of acidic phospholipids PI and PA can be relatively easily obtained from lecithin of plant origin. However, methods for concentrating PS, SM, CL or GS are not disclosed. JP 1026548 5 A describes the preparation of a highly concentrated mixture of PA and PI and a mixture of PE and PC from lecithin using ammonia-containing ethanol. Another more elaborate method is disclosed in US 5,2 14,171 A, which is used to control the dissolution of PC, PE and PA by the use of an alcohol solvent (by appropriately adjusting the acidity of the solvent) I20457.doc 200808817 , adjusting the pH to above 8 to dissolve PC and PE and adjusting to below 5 to dissolve PA) to carry out the extraction step to fractionate the phospholipid mixture into one or two or more of PC, PE, PI and PA or Part of more. The PI is substantially insoluble in the solvent used in the process and is thus primarily recovered in the extraction residue. Other parameters that affect the solubility of the fraction of the phospholipid mixture to be fractionated are the water content of the alcohol solvent, the temperature, and the choice of base and acid to adjust the pH. To further separate the PC and PE rich fractions, a divalent metal 'salt or trivalent metal salt solution is used. A method of concentrating PS, SM, CL or GS is not disclosed. To produce an SM-rich fraction, a mixture containing 5-15% SM is dissolved in an alcohol (optionally containing water) and the solution is concentrated, followed by extraction with an aliphatic hydrocarbon and precipitation with an aliphatic ketone (WO 2000/45828 A1) . A slightly similar method is disclosed in WO 94/18289 A1, in which a phospholipid is mixed with a lower aliphatic alcohol (methanol, ethanol, propanol, butanol) and a substantially non-polar solvent (hydrocarbon or chloroform) to form a non-polar The SM was precipitated by adding a ketone or decyl acetate or ethyl acetate. These methods have the disadvantage of using a variety of solvents to achieve the desired separation. In small-scale laboratory practice, the butanol-water-diisopropyl ether fractionation method is an effective way to prepare GS-rich fractions (Ladish & Gillard 1985). This method can be applied to total lipid extracts of protoplasts, cells or animal tissues. The dried total lipid extract was partitioned in a 3-component solvent system consisting of diisopropyl ether, 1-butanol and 50 M aqueous NaCl (6/4/5, body/volume/volume). The neuroglycolipid is nearly quantitatively soluble into the lower aqueous phase and the other lipids are solubilized to a mixture of the three solvents to produce the upper organic phase. The salt in the aqueous phase containing the nerve glycolipid and other low molecular weight impurities were then removed by gel filtration. God, two, and. Commercial scale manufacturing of sugar sorghum usually involves heating under alkaline conditions with nerve-containing sugars such as white milk or whey protein concentrate (eg

如 US 5,831,079、US 5,795:980、JP 93035 155 B、JP 3615798 B2)。庳注音,太, ^ 在此專條件下幹經結醣脂GD3水解 且形成神經結醣脂咖。其他常用方法包括超濾(例如jp 3 176698 B2、WO 91/074 1 π 十、For example, US 5,831,079, US 5,795:980, JP 93035 155 B, JP 3615798 B2).庳 Phonetic, too, ^ Under this special condition, the dried glycolipid GD3 hydrolyzes and forms a nerve-glycolipid. Other common methods include ultrafiltration (eg jp 3 176698 B2, WO 91/074 1 π,

1/07417)、管柱層析(例如 DE422119G1/07417), column chromatography (eg DE422119G

Al、CA 2002155 a、tt 252310 B)或兩者(例如jp 2207090 A - CN 1379034 A) 〇 如下產生a有至少4%神經結醣脂之組合物:藉由將乙 醇添加至奶或奶製品中以達成3g_7g體積%之最終乙醇濃度 且回收/儿▲ ’接著藉由將乙醇添加至沉殿中以獲得7〇_9〇 體積%之乙醇濃度,蔣哈1 A、 私除蛋白沉澱且薄膜過濾乙醇部分 (US 5,844,104)。 富含神經結醣脂之組合物之製備亦描述於US 6,265,555 中。此專利主張一種自奶或奶來源材料(白脫乳清、白脫 牛奶、乳清及乳清蛋白濃縮物)製造含有神經結醣脂之电 合物之方法’其包含下列步驟:將含有神經結醣脂之材料 分散於乙醇溶液中以使乙醇濃度為隊95% ;將該分散液加 熱至50-贼之溫度以溶解神經結醣脂且同時產生含有蛋 白之第一沉澱;將第一沉澱移除;將除去該第一沉澱之上 清液冷卻至低於〇t之溫度以產生含有神經結醣腊之第二 沉殿;及回收第二沉殿。 在本說明書中,當參考專聋丨士 芩專利成明書、其他外部文獻或其 120457.doc 200808817 轉訊來料,其-般係用於提供封論本發明之特徵之内 容的目的。除非另外特定說明,否 …一 占則對δ亥專外部文獻或該 寻貧訊來源之參考不應解釋為承認該等文獻或該等資訊來 源以任何權限為先前技術或形成此項技術中之通用知 部分。 本發明之目的為提供-種產生含有所需含量之特定鱗月旨 及/或神經結醣脂之產物之方法或至少向公眾提供一曰Al, CA 2002155 a, tt 252310 B) or both (eg jp 2207090 A - CN 1379034 A) 产生 produces a composition having at least 4% nerolipid as follows: by adding ethanol to milk or dairy products To achieve a final ethanol concentration of 3g_7g vol% and recover / ▲ ' and then add ethanol to the sink to obtain an ethanol concentration of 7〇_9〇 volume%, Jiang Ha 1 A, private protein precipitation and membrane filtration of ethanol Part (US 5,844,104). The preparation of a composition rich in nerve glycolipids is also described in US 6,265,555. This patent claims a method for making an antioxidant containing a neuroglycolipid from a milk or milk-derived material (white whey, buttermilk, whey, and whey protein concentrate) which comprises the following steps: The glycolipid material is dispersed in the ethanol solution to make the ethanol concentration 95%; the dispersion is heated to a temperature of 50-thief to dissolve the nerve glycolipid and simultaneously produce a first precipitate containing the protein; Removing; removing the supernatant from the first precipitate to a temperature lower than 〇t to produce a second sink containing the nerve sugar wax; and recovering the second sink. In the present specification, reference is made to the patents of the patents, other external documents, or the like. It is generally used for the purpose of providing a description of the features of the present invention. Unless otherwise specified, no reference to the _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ General knowledge section. It is an object of the present invention to provide a method of producing a product containing a desired amount of a specific squamous cell and/or a neuroglycolipid or at least providing a sputum to the public.

用選擇。 ’、 夯 【發明内容】 因此,本發明提供-種將饋人材料分㈣可溶性成份及 不溶性成份之方法,其包含: ⑷提供包含下列各物中之_或多者之饋人材料: (!)至少1%重量/重量之磷脂醯絲胺酸; (η)至少1%重量/重量之神經鞘磷脂; (ηι)至少1%重量/重量之心磷脂;或 (iv)至少〇·3%重量/重量之祌經結醣脂; (b) ^ 供包含 <_ ρ η - ^ η 及夕種ClrC3—兀醇及水之溶劑,其中 忒一或多種醇之水含量為0至40%體積/體積; (C)使饋入材料與溶劑接觸且隨後將含有可溶性成份 之溶劑與不溶性成份分離; (句視情況分離可溶性成份及溶劑。 饋入材料較佳包含少於10 %之蛋白及少於10 %之乳糖 更佳為少於1〇%之饋入材料包含蛋白及乳糖。 '二 或者儀入材料包含大於i %之填脂酿絲胺酸。镇入材 120457.doc -12- 200808817 料較佳包含大於2%之磷脂醯絲胺酸。饋入材料更佳包含 大於5%之磷脂醯絲胺酸。 或者,饋入材料包含大於1%之神經鞘磷脂。饋入材料 較佳包含大於5%之神經鞘磷脂。饋入材料更佳包含大於 15%之神經鞘填脂。 或者,饋入材料包含大於1%之心磷脂。饋入材料較佳 包含大於2%之心磷脂。饋入材料最佳包含大於5%之心磷 脂。 或者,饋入材料包含大於〇·3%之祌經結醣脂。饋入材料 較佳包含大於1%之神經結醣脂。饋入材料最佳包含大於 2%之神經結醣脂。 本發明之饋入材料可來源於陸地動物、海洋動物、陸地 植物、海洋植物或微生物(諸如微藻類、酵母及細菌)。饋 入材料較佳來源於綿羊、山羊、豬、小鼠、水牛、駱駝、 犛牛、馬、驢、美洲駝、牛或人類。 饋入材料視情況係選自:組織、組織部分、器官、器官 邛刀、奶、奶部分、初乳、初乳部分、血液及血液部分。 饋入材料較佳來源於乳品材料、大豆材料、蛋、動物組 織、動物器官或動物血液。饋入材料更佳係選自:包含乳 口口月曰貝之組合物、包含蛋脂質之組合物及包含海洋生物脂 質之組合物。 用於本發明方法之饋入材料最佳為牛奶部分。饋入材料 車父佳係選自:白脫奶、白脫奶部分、β乳清、β乳清部分、 白脫乳清、白脫乳清部分、乳清、乳清部分、初乳及初乳 120457.doc -13· 200808817 部分。 饋入材料可包含乳脂球膜。 饋入材料可已經基因修飾。 當為固體’在與溶劑接 饋入材料較佳採取固體形式 觸之前.,可低溫碾磨饋入材料 在”岭劑接觸之雨,較佳低溫碾磨用於本發 入材料以達成之平均粒度。 本發明之溶劑較佳包含: 乙醇、正丙醇、異 (幻選自下列各物之醇:甲醇 醇及其混合物;及 (b) 0-40%體積/體積之水。Use the choice. ', 夯 [Summary of the Invention] Accordingly, the present invention provides a method for separating (four) soluble components and insoluble components from a feeding material, comprising: (4) providing a feeding material comprising: _ or more of the following: (! And at least 1% by weight of the phospholipid lysine; (η) at least 1% by weight/weight of sphingomyelin; (ηι) at least 1% by weight/weight of cardiolipin; or (iv) at least 〇·3% Weight/weight 祌 through the glycolipid; (b) ^ for the solvent containing <_ ρ η - ^ η and the genus ClrC3-sterol and water, wherein the water content of the one or more alcohols is 0 to 40% Volume/volume; (C) contacting the feed material with a solvent and then separating the solvent containing the soluble component from the insoluble component; (sequentially separating the soluble component and the solvent. The feed material preferably comprises less than 10% protein and Less than 10% lactose, more preferably less than 1%, of the feed material comprises protein and lactose. 'Second or the instrument material contains more than i% of the fat-filled tyrosine acid. Town material 120457.doc -12- 200808817 preferably contains more than 2% phospholipid lysine. The feed material preferably contains more than 5% phospholipid Alternatively, the feed material comprises greater than 1% sphingomyelin. The feed material preferably comprises greater than 5% sphingomyelin. The feed material preferably comprises greater than 15% sphingolipid. The feed material comprises greater than 1% cardiolipin. The feed material preferably comprises greater than 2% cardiolipin. The feed material preferably comprises greater than 5% cardiolipin. Alternatively, the feed material comprises 祌·3% 祌The glycolipid. The feed material preferably comprises more than 1% of the nerve-glycolipid. The feed material preferably comprises more than 2% of the nerve-glycolipid. The feed material of the present invention can be derived from terrestrial animals, marine animals, land. Plants, marine plants or microorganisms (such as microalgae, yeast and bacteria). Feeding materials are preferably derived from sheep, goats, pigs, mice, buffalo, camels, yaks, horses, donkeys, llamas, cows or humans. The incoming material is selected from the group consisting of: tissue, tissue part, organ, organ file, milk, milk part, colostrum, colostrum part, blood and blood part. The feed material is preferably derived from dairy material, soybean material, egg. Animal organization Animal organ or animal blood. The feed material is more preferably selected from the group consisting of a composition comprising nipple mussels, a composition comprising egg lipids, and a composition comprising marine biological lipids. The feed material for use in the method of the invention. The best part is the milk. The feeding material is selected from: white milk, white milk, beta whey, beta whey, white whey, white whey, whey, whey. Part, colostrum and colostrum 120457.doc -13· 200808817. The feed material may comprise a milk fat globule. The feed material may have been genetically modified. When it is a solid, it is preferably a solid form in contact with the solvent. Previously, the material can be milled at a low temperature in the rain of the contact agent, preferably at a low temperature for the average particle size of the material to be achieved. The solvent of the present invention preferably comprises: ethanol, n-propanol, iso (alcohol selected from the group consisting of: methanol and mixtures thereof; and (b) 0-40% by volume/volume of water.

溶劑更佳包含_2G%體鐘積之間 含1與10%體積/體積之間的水。 y最L 醇較佳為乙醇。 ::!= = =之溶劑較佳包含95%之乙醇水溶液。 至·二門tt劑與饋入材料之比率較佳介於 之門之㈣更佳切2。:1至60 之間。洛劑與饋入材料 主60 本發明之方 杜丄比羊最么介於25··1至40··〗之間。 ’李乂公在鬲於3〇。〇下 佳在高於5〇°c下進广 本喬明之方法j 行。 了。本發明之方法最佳在高於55tn 本發明之方法可以多個、 本發明之方法較件 ,皿度之步騾進行。 议彳土在小於或等於4。 、 方法更佳在小於或等於(TC下進行。 進订。本發明之 120457.doc ,14- 200808817 佳進之步驟_進行1训之間。步驟⑽ 用=:::法二材㈣接η 料可盘—批以卜 I、饋入材料可接觸多次;或饋入材 ^批以上之溶劑接觸。 較佳藉由使用溶劑流經入 材料接觸。 胃入材㈣㈣使洛劑與饋入 3、者籍由授拌來混合溶劑及饋人& #。» 切混合進行攪拌。 ^及饋入材枓較佳猎由高剪 亦提供由本發明方法產生之產物,其為在與溶劑 之不溶性成份(本文亦稱為"殘留物”)及在與 貝入材料接觸之後溶解於溶劑中之可溶 心 為”萃取物”)。當饋入材料盥 〗 文亦稱 批以上之 >谷劑接觸或以多個 ^驟冷部溶劑時,將存在多種”萃取物”產物。 產物較佳含有比饋入材料多的神經鞘麟脂。 產物佳包含大於3%之神經鞘磷脂。產物更佳包含大 於10义之神經鞘磷脂。產物最佳包含大於15%之神經鞘磷 產物較佳含有比饋入材料多的磷脂醯絲胺酸。 產物較佳包含大於5%之磷脂醯絲胺酸。產物更佳包含 大於30%之伽醯絲胺酸:。產物最佳包含大於聰之聲脂 醯絲胺酸。 產物較佳含有比饋入材料多的神經結醣脂。 產物較佳包含大於2%之神經結醣脂。產物更佳包含大 220457.doc 200808817 於4%之神經結醣脂。產物最佳包含大於6%之神經結醣 脂。 產物較佳含有比饋入材料多的心填脂。 產物較佳包含大於5%之心磷脂。產物更佳包含大於10% 之心構腊。產物最佳包含大於2 5 %之心碟脂。 縮寫及首字母縮寫詞 在本說明書中,以下為所用縮寫或首字母縮寫詞之含 義· nPL”意謂磷脂; nCL"意謂心磷脂(二磷脂醯甘油); "PC"意謂磷脂醯膽鹼; ΠΡΙ”意謂磷脂醯肌醇; ΠΡΑΠ意謂磷脂酸; "PS”意謂磷脂醯絲胺酸; ΠΡΕ”意謂磷脂醯乙傳胺; nSM”意謂神經鞘磷脂; ’’DHSM”意謂二氫神經鞘·磷脂; nGSn意謂神經結醣脂; "MFGM”意謂乳脂球膜; ”N/D”意謂未偵測到。 【實施方式】 本發明係基於確認峨脂在短鏈一元醇溶劑中之溶解度存 在著差別。使用此溶解度差別,發明人已發現到可自可溶 性磷脂(包括SM)中分餾出不溶性磷脂(包括PS及CL)及 120457.doc -16- 200808817 GS。 可如以下方式操作此方法中之許多變數以最適化該分 餾: (1) 饋入材料之類型。 各種饋入材料可用於本發明。More preferably, the solvent contains between 1 and 10% by volume of water between _2 G% of the body volume. The y most L alcohol is preferably ethanol. The solvent of ::! = = = preferably comprises a 95% aqueous solution of ethanol. The ratio of the two-part tt agent to the feed material is preferably between the four (4) and the better. : between 1 and 60. Loose agent and feed material main 60 The party of the invention Du Fu than the sheep is between 25··1 to 40··. ‘Li Yugong is at 3〇. His Majesty is better than 5 〇 °c into the wide Qiao Ming method j line. It is. Preferably, the method of the present invention is carried out at a higher than 55 tn. The method of the present invention can be carried out in a plurality of steps of the method of the present invention. The soil is less than or equal to 4. Preferably, the method is performed at less than or equal to (TC. Ordering. 120456.doc of the present invention, 14-200808817 Steps of Jiajin _ between 1 training. Step (10) using =::: method two materials (four) η The material can be disk-batch I, the feed material can be contacted multiple times; or the feed material is contacted with the solvent above the batch. It is better to use the solvent to flow through the material contact. The stomach material (4) (4) the agent and feed 3, the source is mixed with the solvent and the feed &#.» cut mixing for stirring. ^ and the feed material is better hunted by high shear also provides the product produced by the method of the invention, which is in the solvent The insoluble component (also referred to herein as "residue)) and the soluble core dissolved in the solvent after contact with the shelling material are "extracts"). When the material is fed, the article is also referred to as the batch > When the granule is contacted or in a plurality of quenching solvents, a plurality of "extract" products will be present. The product preferably contains more sphingolipid than the feed material. The product preferably contains more than 3% of sphingomyelin. More preferably contains more than 10 sense sphingomyelin. The product preferably contains more than 15% of the gods Preferably, the sheath phosphorus product contains more phospholipids than the feed material. The product preferably comprises greater than 5% phospholipids. The product preferably comprises greater than 30% gamma-serine: the best product Contains more than Congzhisheng lipid lanolinic acid. The product preferably contains more neuroglycolipid than the feed material. The product preferably contains more than 2% of neuroglycolipids. The product preferably contains large 220457.doc 200808817 at 4 % of neuroglycolipids. The product preferably comprises more than 6% of neuroglycolipids. The product preferably contains more heart fat than the feed material. The product preferably contains more than 5% cardiolipin. The product preferably contains greater than 10% of the heart wax. The product preferably contains more than 25% of the heart fat. Abbreviations and acronyms in this manual, the following is the meaning of abbreviations or acronyms used. nPL" means phospholipids; nCL&quot It means cardiolipin (diphospholipid glycerol); "PC" means phospholipid choline; ΠΡΙ" means phospholipid 醯 inositol; ΠΡΑΠ means phosphatidic acid; "PS means phospholipid 醯 lysine; ΠΡΕ" means phospholipids; amines; nSM" means nerves Sphingomyelin; ''DHSM' means dihydrosphingosine; phospholipid; nGSn means neuroglycolipid; "MFGM" means creamy globule membrane; "N/D" means not detected. [Embodiment] The present invention is based on the confirmation that the solubility of rouge in a short-chain monohydric alcohol solvent is different. Using this solubility difference, the inventors have discovered that insoluble phospholipids (including PS and CL) can be fractionated from soluble phospholipids (including SM) and 120457.doc -16 - 200808817 GS. Many of the variables in this method can be manipulated as follows to optimize the fractionation: (1) The type of material being fed. Various feed materials can be used in the present invention.

舉例而言’饋入材料可來源於绵羊、山羊、豬、小鼠、 K牛路I匕犛牛、馬、驢、美洲騎、牛或人類組織、 奶初礼或血液。或者,饋入材料可來源於大豆或其他植 物材料、蛋、動物組織或器官、海洋動物、海洋植物或微 生物。 饋入材料可已經基因修飾。 (2) 饋入材料之粒度(若使用固體原料流)。 小粒度㈣,使得增大總表面積以使可溶性碌脂溶解。 (3) 溶劑類型。 田甲酉子、乙醇、正丙醇及異丙醇及其混合物具有至多 4〇%體積/體積之水時,此等醇均為合適溶劑。 然而,95%體積/體積之乙醇水溶液由於導致PS、CL及 GS之最低溶解度及SM之最高溶解度而為較佳溶劑。 、發明者已發現㈣單-溶㈣統分館所關注之鱗脂及/ 或神經結聽脂可簡化分祕理。避免使用多種_系統及/ 或酸及驗之能力簡化自殘留物及萃取物部分移除溶劍以及 隨後再使用經回收乙醇。 另外,使用單-溶劍(諸如乙醇)意謂不同於與駿或驗或 溶劑(諸如丙酮)共同使用之溶劑,不產生溶劑-脂質反應產 120457.doc -17- 200808817 物。此情況意謂保持殘留物及萃取物產物之自然狀態。 (4)溶劑與原料流之比率。 此比率影響三個主要方面:純度、pS、CL及/或GS產率 及生產量: 純度:溶劑比率越高,殘留物中所獲得之ps、cla/ 或GS之純度就越高。For example, the feed material can be derived from sheep, goats, pigs, mice, K cattle road I yak, horses, donkeys, American riding, cattle or human tissues, milk first gift or blood. Alternatively, the feed material may be derived from soy or other plant material, egg, animal tissue or organ, marine animal, marine plant or microbe. The feed material can have been genetically modified. (2) The particle size of the feed material (if a solid feed stream is used). The small particle size (iv) increases the total surface area to dissolve the soluble fat. (3) Solvent type. When the scorpion scorpion, ethanol, n-propanol and isopropanol and mixtures thereof have up to 4% by volume/volume of water, these alcohols are suitable solvents. However, a 95% by volume/volume aqueous solution of ethanol is a preferred solvent due to the lowest solubility of PS, CL and GS and the highest solubility of SM. The inventors have found that (4) the semen and/or nerve knot hearing lipids of the single-dissolved (four) unified branch can simplify the subtlety. Avoid the use of multiple _ systems and / or acid and test capabilities to simplify the removal of the solution from the residue and extracts and the subsequent use of recovered ethanol. In addition, the use of a mono-solution (such as ethanol) means that the solvent is not used in combination with a solvent or a solvent such as acetone, and does not produce a solvent-lipid reaction 120457.doc -17-200808817. This condition means maintaining the natural state of the residue and the extract product. (4) The ratio of solvent to feed stream. This ratio affects three main aspects: purity, pS, CL, and/or GS yield and throughput: Purity: The higher the solvent ratio, the higher the purity of the ps, cla/ or GS obtained in the residue.

•產率:溶劑比率越高,PS、CL及/或GS之產率就越 低。所有此等化合物在溶劑中均具有極低但有限之溶 解度,且因此比率之增大增加萃取物之損失。 •生產量··溶劑比例越高,生產量就越低。 熟習此項技術者將瞭解在獲得高純度產物中存在競爭約 束,但亦存在最大化產率及生產量之方法。 (5)萃取溫度。 2度越高’殘留物中PS、咖/或仍之純度就越高。$ 回溫度可增加部分可隸磷脂在溶㈣目令之溶解度。^ =二及:或仍之溶解度亦隨溫度務有增加,降㈤ 之產率。溫,度實際上受溶劑滞點限带】。 同上,在獲得高純度產物中存心 大化產率之方法。 中存在…束’但亦細 (6)萃取時間。 卒取進行所允許之時 度。明顯的是,過程耗費: 少。然而,要长充足' 可進行之分批萃取就 於以懸浮顆二溶解可溶性鱗脂。此情況 顆拉形式引入之原料流之萃取極為重要。 120457.doc 200808817 同上,在獲得高純度產物中存在競.IΦ . 大化生產量之方法。 存在…束,但亦存在最 ⑺攪拌。 聚充分以保持顆粒懸浮且藉由使任何形成之 碎而有助於萃取。熟習此項技術者將瞭解在大羯 杈下尚男切混合將最為有利。 然而,雖然擾拌一般垃 _ 版便隶集體破碎,但兩剪切攪拌亦可• Yield: The higher the solvent ratio, the lower the yield of PS, CL and/or GS. All of these compounds have very low but limited solubility in the solvent, and thus an increase in the ratio increases the loss of the extract. • The higher the production volume and solvent ratio, the lower the production volume. Those skilled in the art will appreciate that there is a competitive constraint in obtaining high purity products, but there are also ways to maximize yield and throughput. (5) Extraction temperature. The higher the 2 degree, the higher the purity of the PS, coffee, or still in the residue. The back temperature can increase the solubility of some of the phospholipids in the dissolved (four) order. ^ = 2 and: or the solubility still increases with temperature, decreasing the yield of (5). Temperature, the degree is actually limited by the solvent stagnation point]. As above, a method of achieving high yield in obtaining a high-purity product. There is a bunch of 'but' but also fine (6) extraction time. The time allowed for the stroke to proceed. Obviously, the process costs: less. However, to be long enough, the batch extraction that can be carried out is to dissolve the soluble scales in suspension. In this case, the extraction of the feed stream introduced by the pull form is extremely important. 120457.doc 200808817 Ibid. In the process of obtaining high-purity products, there is a method of increasing the production volume. There are ... bundles, but there is also the most (7) agitation. The poly is sufficient to keep the particles suspended and to facilitate extraction by breaking any formation. Those skilled in the art will understand that it is most beneficial to have a mix of men and women under the squat. However, although the disturbance is generally _ version will be collectively broken, but the two shear mixing can also

士夏里‘致顆粒聚集以形成聚集體。當使用次最優攪拌 作匕合速度、葉輪類 J 铷頦型及尺寸之因素開始起作用時,其為按 比例增加之真實風險。 、田田3月曰貝之饋入材料為固體時,亦可能在無攪拌的债 兄下使用填料床進行分離製程。可在低溫下使溶劑通過經 研磨饋人材料之填料床以萃取具有最高溶解度(及最低溶 ’)之化&物,接著升南溫度(分階段或連續)直至達到在殘 留物十得到最高純度PS、CL及/或GS之所需最終温度。此 方法使用/JHL度而非溶劑與原料流之比率達成分顧。在低溫 下(10-2QC)PC選擇性地溶解。可接著完成 隨後之溫度步驟 以知除更多之可溶性磷脂(pE、SM& ρι)直至介於5〇它與 60 C之間的最終步驟。所得填料床富含朽及/或^^及神經 結醣脂且為粉末狀沉殿。 (8)水與溶劑之比率 在低水含量(<6%)下,與其他磷脂相比相對以及/或以純 度南’ PS及/或CL之回收率良好且所得含有Ps、CL及/或 120457.doc -19- 200808817 GS之不溶於溶劑中之部分為易於處理之粉末。在低水含量 下SM亦高度可溶於溶劑中。隨著水含量增加,PS在溶劑 中變得更可溶,而PC及SM溶解度降低,導致較差之分離 及較低之產率。 (9) pH值 儘管酸性條件使得PS稱微富集,但pH值在2-9範圍内不 影響分餾。然而,酸之使用使方法複雜化且導致韻外成 本。 如將由熟習此項技術者所瞭解,可在必要時操縱上述變 數以優化可溶性產物之組成(例如SM含量)。 如本文所用之術語”來源"意謂起源於。 如本說明書中所用之術語"包含”意謂’’至少部分由......組 成”。當解釋本說明書中包括術語”包含"之各陳述時,亦 可存在除以該術語開頭之特徵以外的特徵。諸如"包含”之. 相關術語將以相同方式進行解釋。 除非另有說明,否則百分率係以重量/重量固體計。 本發明由以上内容組成且亦設想僅構建以下實例來說明 之 實例 實例1 :乳品原料流之單鍋攪拌槽乙醇萃取 使用PCT國際申請案PCT/NZ2004/000014(作為WO W02004/066744 公開)A PCT/NZ2005/000262( # ^ WO 2006/04 1316公開)中所揭示之方法獲得均來源於牛白脫奶 之富含MFGM部分之此等原料流,其具有不同的磷脂及神 120457.doc -20- 200808817 經結醣脂組成。 原料流A :脂質含量高(改良型羅斯-高特裏巴法 (Modified Roese-Gottlieb)至多 94%脂質),大約 32%石粦脂及 2.3%神經結醣脂。藉由近臨界二甲醚萃取具有>^乳糖含量 之牛白脫奶之富含MFGM部分來產生此原料流。 原料流B :含有65重量%之高含量磷脂。在近臨界二甲 醚萃取之前藉由超臨界C〇2萃取具有低乳糖含量之牛白脫 奶之富含MFGM部分(以移除中性脂質)來產生此原料流。Shihari's granules aggregate to form aggregates. When suboptimal agitation is used as the kneading speed, the impeller type and the size factor begin to function, it is a real risk of proportional increase. When the feed material of the Tianbei mussels in March is solid, it may also be separated by a packed bed under the unstirred debt. The solvent can be passed through a packed bed of grounded feed material at a low temperature to extract the highest solubility (and lowest solubility) and then rise to the south temperature (staged or continuous) until the maximum is reached in the residue ten. The desired final temperature for purity PS, CL and/or GS. This method uses /JHL degrees instead of the ratio of solvent to feed stream. The PC was selectively dissolved at a low temperature (10-2 QC). The subsequent temperature step can then be followed to remove the more soluble phospholipids (pE, SM & ρι) until a final step between 5 〇 and 60 C. The resulting packed bed is rich in turmeric and/or ^TM and neurolipids and is a powdered sink. (8) The ratio of water to solvent at a low water content (<6%), relative to other phospholipids and/or a good recovery of purity South 'PS and/or CL and the resulting Ps, CL and/ Or 120457.doc -19- 200808817 The part of GS that is insoluble in solvents is a powder that is easy to handle. SM is also highly soluble in solvents at low water contents. As the water content increases, PS becomes more soluble in the solvent, while the solubility of PC and SM decreases, resulting in poor separation and lower yield. (9) pH Although the acidic condition makes the PS slightly enriched, the pH does not affect the fractionation in the range of 2-9. However, the use of acid complicates the process and results in extravagant costs. As will be appreciated by those skilled in the art, the above variables can be manipulated as necessary to optimize the composition of the soluble product (e.g., SM content). The term "source" as used herein means originating from. The term "comprising" as used in this specification means ''consisting at least in part." In the statements of ", there may be features other than those beginning with the term. Terms such as "include" will be interpreted in the same manner. Unless otherwise stated, the percentages are based on weight/weight solids. The present invention consists of the above and is also contemplated to be constructed by the following examples only. The method of the invention disclosed in PCT/NZ2004/000014 (published as WO W02004/066744) A PCT/NZ2005/000262 (published in WO 04/04 1316). These feed streams are obtained from the MFGM-rich portion of the bovine white de-milk, which have different phospholipids and are composed of glycosidic fat. Raw material stream A: high lipid content (modified Rose) - Modified Roese-Gottlieb (up to 94% lipid), approximately 32% sarcophagus and 2.3% nerolipid. Extracted with near-critical dimethyl ether with > The milk is rich in MFGM to produce this feed stream. Feed stream B: contains 65% by weight of high-concentration phospholipids. Extraction of bovine white milk with low lactose content by supercritical C〇2 prior to near-critical dimethyl ether extraction Rich in MFGM Min (to remove neutral lipids) to generate this feed stream.

原料流C :原料流C具有極高脂質含量及比原料流A按比 例更高之鱗脂量,但幾乎無神經結醣脂。藉由近臨界二甲 醚萃取具有低乳糖含量之牛白脫奶之富含MFGM部分來產 生此原料流。 三種原料流之磷脂及神經結醣脂組成列於下表1中。 表1 ·原料流A - C之填脂及神經結釀脂組成 原料流 A B C % PL 31.0% 65.6% 41.7% Pk% PC 23.7% 23.4% 26.9% PI 8.2% 8.1% 6.8% PS 12.7% 12.2% 10.4% PE 33.1% 32.9% 31.8% SM 18.3% 18.8% 18.8% DHSM 3.7% 4.2% % PS 3.9% 8.0% 4.3% % SM 6.8% 15.1% 7.8% GS 2.3% 3.6% 0.6% 在高於50t:之溫度下將各原料流引入過量溶劑(95%乙 醇)中且攪拌預定時長。在此過程中,將可溶於乙醇中之 120457.doc -21 - 200808817 填脂溶解於乙醇中,產生萃取物流,且留下不_材料㈣ 留物”),該材料結果具有富集含量之ps&GS。 萃取之細節提供於以下實例1 a-1 d中。 用於將此專原料流引入溶劑中之選擇。 原料流B在所有實際處理溫度下均為固體膠狀物,因此 在乙%萃取之前其要求低溫碾磨。因此,對於此方法而 原料流A及原料流c最易於處理。該等原料流在利它下為 液體且因此可抽汲。該等原料流在〇。。下亦均為固體且因 此可經由粉碎機饋入。由於在高溫下使甩&醇時任—形式 (液體或冷幻之此等原料流均切溶解,所以其提供兩種Feed stream C: Feed stream C has a very high lipid content and a higher proportion of scale than feed stream A, but is almost free of gangliolipids. This feed stream is produced by extracting the MFGM-rich portion of the bovine white milk which has a low lactose content by near-critical dimethyl ether. The composition of the phospholipids and neuroglycosmic lipids of the three feed streams are listed in Table 1 below. Table 1 · Filling of raw material stream A - C and nerve knots. Composition of raw materials ABC % PL 31.0% 65.6% 41.7% Pk% PC 23.7% 23.4% 26.9% PI 8.2% 8.1% 6.8% PS 12.7% 12.2% 10.4 % PE 33.1% 32.9% 31.8% SM 18.3% 18.8% 18.8% DHSM 3.7% 4.2% % PS 3.9% 8.0% 4.3% % SM 6.8% 15.1% 7.8% GS 2.3% 3.6% 0.6% Above 50t: Temperature Each feed stream was introduced into an excess of solvent (95% ethanol) and stirred for a predetermined period of time. In this process, 120457.doc -21 - 200808817 fat-soluble in ethanol is dissolved in ethanol to produce an extract stream, leaving no material (four) residue "), the material results in an enriched content Ps&GS. The details of the extraction are provided in the following Examples 1 a-1 d. The choice to introduce this specific feed stream into the solvent. Feed stream B is a solid gel at all actual processing temperatures, so in B Before the extraction, it requires low temperature milling. Therefore, for this method, the raw material stream A and the raw material stream c are the easiest to handle. The raw material streams are liquid under the alkaloid and thus can be pumped. The bottom layer is also solid and can therefore be fed via a pulverizer. Since the 甩& alcohol is in any form at the high temperature (liquid or cold phantom such material stream is uniformly dissolved, it provides two

言,原料流B在引入溶劑前需要碾磨成精細粉末(其要求低 温碾磨)。此額外處理步驟增加成本,使原料流B顯著比原 料流A或原料流C處理起來更昂貴。亦存在未充分碾磨原 料流B之風險,其將危害該方法且導致所得純度較低。然 而,可藉由首先將原料流分散於少量溶劑中來克服此問 題。 由於高中性脂質含量,原料流A及原料流c在高溫下為 液體,而由於低中性脂質含量,原料流叫所有實用溫度 下均為固體。 實例la 1·將100 mL 95%乙醇置於6〇。〇水浴中之1〇() m]L蕭特瓶 (Schott bottle)中。 2·由頂置式授拌态(janke&Kunkel IKA- WERK RW20頂置 式攪拌器)攪拌乙醇直至溫度達到6〇〇c。 120457.doc -22- 200808817 3 ·將大約2· 5 g原料流A稱入1 〇 ml注射器中。 4 ·接者將注射器加熱至c以液化原料流。 5·接著藉由壓下注射器將液化原料流八經5分鐘時間添加 至乙醇中。 6·接著將原料流/乙醇混合物在6〇t下攪拌2小時。 7·接者使溶液通過Whatman 4濾紙且收集〇 235 g不溶性材 料(殘召物)。通過濾紙之乙醇混合物含有殘留之2.265 _ 公克磷赌材料(萃取物)。 8.由P-NMR分析殘留物及萃取物部分之磷脂含量。如表 2中所示發現殘留物高度富含ps(未量測(3§含量卜亦如 表2中所示發現萃取物組合物具有富集含量之8]^。 實例lb 1·將100 mL 95%乙醇置於由6(rc水浴加熱之夾套中之1〇〇 mL蕭特瓶中。 2.由磁力攪拌器(Janke&Kunkel IKA Lab〇rtechnik r(:i^ 書 本磁力攪拌裔)攪拌乙醇直至其溫度達到6〇°C。 3 ·將2 · 1744 g原料流a添加至1 〇 mi注射器中。 4·接著將注射器加熱至6〇〇q以液化原料流。 5·接著藉由壓下注射器將液化原料流八經5分鐘時間添加 至乙醇中。 6·接著將原料流/乙醇混合物在6〇它下攪拌2小時。 7·接著使溶液通過貿“蚀抓4濾紙且收集〇i45 g不溶性材 π (戔召物)通過濾紙之乙醇混合物含有殘留之2.〇294 公克碟脂材料(萃取物)。 120457.doc -23 - 200808817 8.由31P-NMR分析殘留物部分之磷脂含量。如表2中所示 發現殘留物南度富含p S (未量測g §含量)。 實例lc 本實例展示一種處理富含固體脂質之基質之方法。 1·低溫碾磨24.6公克原料流B。 2·將經碾磨材料置於1 l蕭特瓶中且在<4°c之溫度下將2⑽ mL· 95%乙醇傾入瓶中。 3·將瓶子置於設定在65。(:之溫控水浴中。如實例邝一樣進 行攪拌。The feed stream B needs to be milled into a fine powder (which requires low temperature milling) before it is introduced into the solvent. This additional processing step adds cost and makes the feed stream B significantly more expensive to process than the feed stream A or feed stream C. There is also a risk of insufficient milling of the raw stream B, which would jeopardize the process and result in lower purity. However, this problem can be overcome by first dispersing the feed stream in a small amount of solvent. Due to the high to medium lipid content, feed stream A and feed stream c are liquid at elevated temperatures, and due to the low neutral lipid content, the feed stream is solid at all practical temperatures. Example la 1· 100 mL of 95% ethanol was placed at 6 Torr. In the water bath, 1 〇 () m] L Schott bottle. 2. Stir the ethanol from the overhead mixing state (janke & Kunkel IKA-WERK RW20 overhead stirrer) until the temperature reaches 6 〇〇c. 120457.doc -22- 200808817 3 • Weigh approximately 2.5 gram of feed stream A into a 1 〇 ml syringe. 4 • The receiver heats the syringe to c to liquefy the feed stream. 5. The liquefied feed stream was then added to the ethanol over a period of 5 minutes by depressurizing the syringe. 6. The feed stream/ethanol mixture was then stirred at 6 Torr for 2 hours. 7. The receiver passes the solution through Whatman 4 filter paper and collects 235 g of insoluble material (residual material). The ethanol mixture passing through the filter paper contained a residual 2.265 gram of phosphorous gambling material (extract). 8. Analysis of the phospholipid content of the residue and extract fraction by P-NMR. As shown in Table 2, the residue was found to be highly enriched in ps (unmeasured (3 § content is also found in the extract composition as shown in Table 2). Example lb 1 · 100 mL 95% Ethanol was placed in a 1 〇〇 mL Schott bottle in a 6 (rc bath heated jacket) 2. Stirred ethanol by a magnetic stirrer (Janke & Kunkel IKA Lab〇rtechnik r (: i^ book magnetic stirrer) Until the temperature reaches 6 ° C. 3 · Add 2 · 1744 g of raw material stream a to the 1 〇mi syringe. 4. Then heat the syringe to 6 〇〇q to liquefy the feed stream. 5 · Then by pressing The syringe was used to add the liquefied feed stream to the ethanol over a period of 5 minutes. 6. The mixture of the feed stream/ethanol was then stirred under 6 Torr for 2 hours. 7. The solution was then passed through a trade "cracking 4 filter paper and collecting 〇i45 g. The insoluble material π (the object) passed through the ethanol mixture of the filter paper containing the residual 2. 〇 294 g of the disc grease material (extract). 120457.doc -23 - 200808817 8. The phospholipid content of the residue fraction was analyzed by 31P-NMR. As shown in Table 2, the residue was found to be rich in p S (unmeasured g § content). Example lc A method for treating a solid lipid-rich substrate is shown. 1. Low temperature milling 24.6 grams of raw material stream B. 2. Place the milled material in a 1 l Schott bottle and at a temperature of < 4 ° C 2 (10) mL·95% ethanol was poured into the bottle. 3. Place the bottle in a temperature-controlled water bath set at 65. Stir as in the case.

接著在65°C之溫度下將800 mL 95%乙醇添加至瓶中之 混合物中以獲得1:5 0之原料與溶劑比。 連續攪拌原料流/乙醇混合物且將溫度維持在65它下。 3小時後,傾倒乙醇混合物通過貿以加扣4濾紙且收集 6.8公克不溶性材料(殘留物)。通過濾紙之乙醇混合物 (萃取物)含有殘留之17.3公克磷脂材料。 由31P-NMR分析殘留物及萃取物部分之磷脂含量。如表 2中所不發現殘留物高度富含”及GS。亦如表2中所示 發現萃取物組合物具有富集含量之。 實例Id 本實例展示當原料流含低含量仍及乳糖時,ps經實質 上富集。 1.將100公克95%乙醇置於具有磁力攪拌器之加熱板上之 100 mL燒杯中,且在將溫度升高至65它的同時如實例 lb—樣攪拌。 、 120457.doc -24- 200808817 2.將2.0公克原料流C添加至乙醇中,且將混合物在饥下 連續攪拌2小時。 接著傾倒混合物通過Whatman 4濾紙且收集〇12邑不溶 性材料(殘留物)。通過濾紙之乙醇混合物(萃取物)含有 殘留之1·87公克磷脂材料。 4.由31P-NMR分析殘留物及萃取物部分之磷脂含量❶如表 2中所示發現殘留物高度富含ps。亦如表2中所示發現 萃取物組合物具有高含量之SM。 表2展示由此方法獲得之結果。 表2 ·由實例1之方法獲得之結果之比較Next, 800 mL of 95% ethanol was added to the mixture in the bottle at a temperature of 65 ° C to obtain a 1:50 raw material to solvent ratio. The feed stream/ethanol mixture was continuously stirred and the temperature was maintained at 65. After 3 hours, the ethanol mixture was poured through a trade to add 4 filter paper and 6.8 grams of insoluble material (residue) was collected. The ethanol mixture (extract) passing through the filter paper contained 17.3 grams of residual phospholipid material. The phospholipid content of the residue and the extract fraction was analyzed by 31 P-NMR. The residue was found to be highly enriched as shown in Table 2 and GS. The extract composition was found to have an enriched content as shown in Table 2. Example Id This example shows that when the feed stream contains low levels of lactose, The ps is substantially enriched. 1. Place 100 grams of 95% ethanol in a 100 mL beaker on a hot plate with a magnetic stirrer and stir as in Example lb while raising the temperature to 65. 120457.doc -24- 200808817 2. 2.0 g of feed stream C was added to the ethanol and the mixture was continuously stirred for 2 hours under starvation. The mixture was then poured through Whatman 4 filter paper and 〇12邑 insoluble material (residue) was collected. The ethanol mixture (extract) passing through the filter paper contained 1.87 grams of residual phospholipid material. 4. The phospholipid content of the residue and the extract fraction was analyzed by 31P-NMR. As shown in Table 2, the residue was found to be highly enriched in ps. The extract composition was also found to have a high content of SM as shown in Table 2. Table 2 shows the results obtained by this method. Table 2 - Comparison of the results obtained by the method of Example 1.

33

laA b 雜 %|2.2 6 7 .8-.7.06 0 2.1852221.0.laA b Miscellaneous %|2.2 6 7 .8-.7.06 0 2.1852221.0.

Jrl31.04.5324222:25.1 5Jrl31.04.5324222:25.1 5

AA

1CB 物 留 殘 ^1.916.1117.53 物 萃 % 3 9 物 留殘一 or 5 % 6 27. .71 6.1.5.57 9 3.1844272.0.1CB residue [1.916.1117.53] Extract % 3 9 Residue or 5 % 6 27. .71 6.1.5.57 9 3.1844272.0.

Idc 物 Ϊ172 63 .63 6.3.2 295.2.3422 6%9.3 8 8 0.7. 5 2· ο ο ο 6.0.0. 50 9441 29 6.132220. %n.64 2.8.80Idc Ϊ172 63 .63 6.3.2 295.2.3422 6%9.3 8 8 0.7. 5 2· ο ο ο 6.0.0. 50 9441 29 6.132220. %n.64 2.8.80

%PS % SM+DHSM 32.7 1.0 0.8 10.2 38.9 1.0 23.0 1.9 1.7 17.4 73.7 0.0 0.5 9.3%PS % SM+DHSM 32.7 1.0 0.8 10.2 38.9 1.0 23.0 1.9 1.7 17.4 73.7 0.0 0.5 9.3

GS 6.0 2.7 實例le-低溫萃取 本實例展示低處理溫度導致!>8之低富集程度。 1.低溫礙磨0·7857公克原料流B且置於50 mL離心管中。 2·接著在37T:之溫度下將47·5 mL 95%乙醇添加至管子 120457.doc -25- 200808817 中’接著將該管子添加至設定在37t:下之機械震屋器式 水浴中之混合架中。 3·接著在3rc下進行攪拌2小時,且接著使混合物通過 Whatman 4濾紙。 收集0·28公克不溶性材料(殘留物)且發現其具有19斗%之 p s含量(31Ρ-NMR分析)。 實例2 :乳品原料流之多步驟樣拌槽乙醇萃取 參 纟實例展示使用低於實例i中所用之溶劑原料比的溶劑 原料比的多步驟攪拌槽萃取方法亦可達成ps&Gs之顯著 畐集。 實例丨之原料流B亦用於本實例中。如實例丨一樣在引 入溶劑中之前將原料流3低溫碾磨成精細粉末。 如下進行該方法:GS 6.0 2.7 Example le-Cryogenic Extraction This example demonstrates the low enrichment temperature resulting in a low processing temperature of >8. 1. Low temperature obstructs 0.7857 grams of feed stream B and is placed in a 50 mL centrifuge tube. 2. Then add 47·5 mL of 95% ethanol to the tube 120457.doc -25- 200808817 at 37T: then add the tube to the mixing in a mechanical shaker water bath set at 37t: In the rack. 3. The stirring was then carried out at 3 rc for 2 hours and then the mixture was passed through Whatman 4 filter paper. 0·28 g of insoluble material (residue) was collected and found to have a p s content of 19% by weight (31 Ρ-NMR analysis). Example 2: Multi-step mixing tank for dairy feed stream Ethanol extraction of ginseng examples shows that a multi-step stirred tank extraction method using a solvent to raw material ratio lower than the solvent raw material ratio used in Example i can also achieve a significant set of ps&Gs . The example feed stream B is also used in this example. Feed stream 3 was cryogenically milled to a fine powder prior to introduction into the solvent as in Example 。. Do this as follows:

將500公克經低溫碾磨之原料流B置於5 l容器中,且在 65°C下添加5 L 95%乙醇。 週期性震盪容器且藉由將容器置於熱水浴中而將溫度 維持在65°C下。 J時後,V止震盪且使不溶性材料沉入容器底部。 4·傾析溶劑相且保留。 5. 回收來自此第一萃取之固體材料,冷凌且低溫再礙 磨。 6. 將。經再碾磨之材料置於5 L容器中且在6穴下添加5 l ,5%乙醇。接著週期性震盪容器且藉由將容器置於熱 水浴中而將溫度維持在65它下。 I20457.doc -26- 200808817 7· 1小日守後’使溶液濾過Whatman 4濾紙且收集粉末殘留 物。回收溶劑栢且與來自第一萃取之溶劑相合併。 8·將粉末殘留物置於5 L容器中且在65它下添加5 L 95% 乙醇。週期性震蘯容益且藉由將容器置於熱水浴中而 將溫度維持在65°C下。 9. 2小時30分鐘後,使混合物濾過Whatman 4瀘紙。冷康 乾燥所回收之固體’得到125.3 g粉末("殘留物”)。收 集濾液且蒸發(”萃取物4”)。 1 〇·將來自步驟7之經合併溶劑相在2〇艺下保持4天,在此 期間磷脂發生進一步沉澱。接著使溶液濾過Whatman 4 濾紙。收集粉末殘留物且冷凍乾燥(78 8 g粉末,萃取 物1 ”)。收集濾液且在冷藏器中在<0。〇下儲存24小時, 此導致進一步沉澱,在此之後將其據過Whatman 4濾 紙。接著收集濾液,蒸發且冷凍乾燥,且產生11〇 6公 克粉末("萃取物2")。冷凍乾燥過濾固體,產生85.〇 g 粉末(”萃取物3”)。 11.由31p-nmr分析殘留物及萃取物1-4之磷脂含量。發現 殘留物高度富含PS及GS。組成展示於表3中。 ' 表3展示由此方法獲得之結果。 120457.doc -27- 200808817 表3 ··來自多步驟萃取之殘留物及萃取物部分組成 原料流 B _ 產出 殘留物 萃取物1 萃取物2 萃取物3 萃取物4 產率(固體、 25% 16% 22% 17% 6% % PL 52 47 70 73 L 63 PL PC 1 11 53 24 to 之% PI 23 10 0 1 1 ία PS 46 6 0 1 I \J PE 28 36 28 31 D SM 0 37 18 43 JO 17 %PS 24 3 0 1 % SM 0 17 12 31 L 11 GS 6.0 4.2 0.0 0.4 實例3:固體原料流之填料床乙醇萃取 本實例展示亦可在無攪拌的情況下使用填料床方法分離 磷脂之固體混合物。使用乳品原料流B,但通用方法可應 用於大豆印磷脂及來自動物器官及組織之磷脂濃縮物。將 原料流低溫碾磨成精細粉末。 此方法使用溫度而非溶劑與原料流比達成分餾。 、.此方法經發展以克服當在方法(諸如實例丨及實例2中所 述之方去)中使用原料流B(或其他含有極低含量中性脂質 之原料流)時所觀察到之"膠著,,及聚集問題。 、 目前相信”膠著”係ώ去古八★ & 係由未充分洛解且形成凝膠之磷脂醯膦 驗(pc)引起。此填料庆太 ° 一 具Τ十尿方法耩由使用低溫步驟(1〇-20。〇減 輕此問題。 度II圍中,PC選擇性地溶解,且由於不存在溶解 之mm ’ 自填料床移除而不會形成凝谬。 J20457.doc -28- 200808817 接著可完成升溫步驟以 (PE^ SM^PI)i^ L之間的最終步騾。 所得填料床富含以及处 ώ 6f>〇r . 、、=、、々醣如且為粉末狀沉澱。 ;在60 c以上之溫度妈〜500 grams of the cryogenically milled feed stream B was placed in a 5 l vessel and 5 L of 95% ethanol was added at 65 °C. The vessel was periodically shaken and the temperature was maintained at 65 ° C by placing the vessel in a hot water bath. After J, the V stops and causes the insoluble material to sink to the bottom of the container. 4. Decanse the solvent phase and retain. 5. Recycle the solid material from this first extraction, cold and low temperature. 6. Will. The remilled material was placed in a 5 L vessel and 5 l, 5% ethanol was added at 6 cavities. The vessel was then periodically shaken and the temperature was maintained at 65 by placing the vessel in a hot water bath. I20457.doc -26- 200808817 7·1 small day shoud' The solution was filtered through Whatman 4 filter paper and the powder residue was collected. The solvent is recovered and combined with the solvent from the first extraction. 8. Place the powder residue in a 5 L vessel and add 5 L 95% ethanol at 65. The capacity was periodically shocked and the temperature was maintained at 65 ° C by placing the vessel in a hot water bath. 9. After 2 hours and 30 minutes, the mixture was filtered through Whatman 4 crepe paper. The solid recovered from the cold drying 'received 125.3 g of powder ("residue)). The filtrate was collected and evaporated ("extract 4"). 1 〇· The combined solvent phase from step 7 was maintained at 2 〇 The phospholipids were further precipitated during the 4 days. The solution was then filtered through Whatman 4 filter paper. The powder residue was collected and lyophilized (78 8 g powder, extract 1 ′). The filtrate was collected and at <0 in a freezer. Storage under the arm for 24 hours resulted in further precipitation, after which it was passed on Whatman 4 filter paper. The filtrate was then collected, evaporated and lyophilized to yield 11 〇 6 gram of powder ("extract 2"). The solid was filtered by lyophilization to yield 85. g g powder ("Extract 3"). 11. Analysis of the phospholipid content of the residue and extracts 1-4 from 31 p-nmr. The residue was found to be highly rich in PS and GS. The composition is shown in Table 3. 'Table 3 shows the results obtained by this method. 120457.doc -27- 200808817 Table 3 · Residues and extracts from multi-step extraction Partial composition B _ Output residue extract 1 Extract 2 Extract 3 Extract 4 Yield (solid, 25% 16% 22% 17% 6% % PL 52 47 70 73 L 63 PL PC 1 11 53 24 to % PI 23 10 0 1 1 ία PS 46 6 0 1 I \J PE 28 36 28 31 D SM 0 37 18 43 JO 17 %PS 24 3 0 1 % SM 0 17 12 31 L 11 GS 6.0 4.2 0.0 0.4 Example 3: Packed bed ethanol extraction of solid feed stream This example shows the separation of phospholipids using a packed bed method without agitation Solid mixture. Use dairy feed stream B, but the general method can be applied to soy-printed phospholipids and phospholipid concentrates from animal organs and tissues. The raw material stream is cryogenically milled into a fine powder. This method uses temperature instead of solvent and feed stream. It is developed to overcome the use of feed stream B (or other feed stream containing very low levels of neutral lipids) in processes such as those described in the Examples and Example 2. Observed the "glue, and aggregation problems. It is believed that the "glue" system is caused by the phospholipid phosphine test (pc) which is not fully resolved and forms a gel. This filler is too ° 一 一 一 一 耩 耩 耩 耩 耩 耩 耩 使用 使用 使用 使用〇-20.〇 Alleviate this problem. In the degree II, the PC selectively dissolves and does not form a coagulation due to the absence of dissolved mm' removed from the packed bed. J20457.doc -28- 200808817 The temperature rising step is the final step between (PE^SM^PI)i^L. The resulting packed bed is rich and is in the form of 6f>〇r.,, =, and sucrose as a powdery precipitate. c above the temperature mom ~

Tps、交侍可溶且可經歷顯著損 失因此此方法亦為有利的。 捐 此技術之另一優點為降 Λ 馮除去對鬲剪切攪拌之需要。雖鈇俨 拌一般使聚集體破碎,作古 …、見This method is also advantageous in that Tps, delivery is soluble and can experience significant losses. Another advantage of donating this technique is the need to reduce the need for shear mixing. Although the mixture is generally broken, the aggregates are broken.

粒聚集以形成聚集體。者佬爾Αί里TV致顆 m與〜 田使用次最優攪拌時,此情況為— 問碭。舉例而言,當如貯样 槽直仏及问度、混合速度、葦 類型及尺寸之因素開私4p从m 士 茶輪 ’、口赵作用時’其為按比例增加之直余 風險。 ,、灵 緩流體動力學使原料 而形成聚集體之機率 另外,此方法使用非混合(層狀)平 與乙醇接觸,因此存在最少碰撞且因 更小。 以下列方式進行該方法: 1. 將已知量之經碾磨原料流B(5 1〇62公克)平均分散於夾 套燒結過瀘器内部。、 2. 使燒結夾套與具有泵之溢控水浴連接。 3·將水浴設為l〇°C。 4.將100 mL 95%乙醇(體積等於原料流B之量之2〇倍,例 如母1公克原料流B對應2 0 mL乙醇)量入容器中且置於 水浴中。 5·在乙醇及床達到i〇°c之後,將乙醇傾入燒結物之頂部 且經床流入燒瓶中。 6·再循環乙醇且連續通過床傾倒24分鐘。將床中在丨〇。〇 120457.doc -29- 200808817 下可溶之材料溶於乙醇中。 7.接著收集乙醇及第一磷脂萃取物,且蒸發乙醇,得到 〇·613公克表4中描述為〗〇艺萃取物之磷脂混合物。 8·將水浴溫度升至T2(20°C)。 9·夏出1〇〇 mL新鮮95%乙醇且置於水浴中。 1〇·在乙醇及床達到丁2(2〇\:)之後,將乙睁傾入燒結物之 頂部且經床流入燒瓶中。 _ π·回收乙醇且連續通過床傾倒28分鐘。將床中在加。^下 可溶之材料溶於乙醇中。 12·接著收集乙醇及第二磷脂萃取物,得到1〇21公克表4 中描述為20°C萃取物之磷脂混合物。 13 ·將水浴溫度升至3〇°c。 14.量出1〇〇 mL新鮮95%乙醇且置於水浴中。 15·在乙醇及床達到30它之後,將乙醇傾入燒結物之頂部 且經床流入燒瓶中。 φ 16·回收乙醇且連續通過床傾倒30分鐘。將床中在3(Γ(:下 可溶之材料溶於乙醇中。 17·接著收集乙醇及第三磷脂萃取物,得到〇·97〇公克表4 中描述為30°C萃取物之磷脂混合物。 ; 18.將水浴溫度升至50°C 〇 19·量出1〇〇 mL新鮮95%乙醇且置於水浴中。 20.在乙醇及床達到50t:之後,將乙醇傾入燒結物之項部 且經床流入燒瓶中。 21 ·回收乙醇且連續通過床傾倒5 3分鐘。將床中在$ 〇 ^下 120457.doc -30- 200808817 可溶之材料溶於乙醇中。 22.揍著收集乙醇及第四磷脂萃取物,得到公克表4 中描述為50°C萃取物之磷脂混合物。 23·將水浴溫度升至6〇°C。 24.量出1〇〇 mL新鮮95%乙醇且置於水浴中。 2 5 ·在乙醇及床達财㈣。c之後,將乙醇傾入燒結物之頂部 且經床流入燒瓶中。 26·回收乙醇且連續通過床傾倒22分鐘。將床中在6〇。〇下 可溶之材料溶於乙醇中。 27.接著收集乙醇及第五磷脂萃取物,得到〇117公克表4 中描述為6 0 C %取物之填脂混合物。 28·收集床殘留物1 277公克,發現其含有高含量之1>8及神 經結醣脂。其在表4中被描述為殘留物。 表4展示由此方法獲得之結果。 表4 :由實例3之方法獲得之結果The particles aggregate to form aggregates. When the 佬尔Αί里 TV is given to m and ~ the field is used for optimal mixing, this situation is - ask. For example, when the factors such as the straightness and the degree of the storage tank, the mixing speed, the type of the enthalpy, and the size of the sump are used to open the privilege, the risk is proportional to the increase. , the possibility of slow fluid dynamics to form aggregates of raw materials. In addition, this method uses non-mixed (layered) flats in contact with ethanol, so there is minimal collision and smaller. The process was carried out in the following manner: 1. A known amount of milled feed stream B (5 1 〇 62 g) was dispersed evenly inside the jacketed sintered vessel. 2. Connect the sintered jacket to the overflow water bath with pump. 3. Set the water bath to l〇 °C. 4. Pour 100 mL of 95% ethanol (2 times the volume of the feed stream B, for example 1 g of the parent feed B to 20 mL of ethanol) into a container and place in a water bath. 5. After the ethanol and the bed reached i〇°c, the ethanol was poured into the top of the sinter and passed through the bed into the flask. 6. Recycle ethanol and continuously pour through the bed for 24 minutes. Put the bed in the raft. 〇 120457.doc -29- 200808817 The soluble material is soluble in ethanol. 7. The ethanol and the first phospholipid extract were then collected and the ethanol was evaporated to give 磷脂6133 g of the phospholipid mixture described in Table 4 as a decanted extract. 8. Increase the temperature of the water bath to T2 (20 ° C). 9·Summer 1〇〇 mL fresh 95% ethanol and placed in a water bath. 1〇 After the ethanol and the bed reached D2 (2〇\:), the acetamidine was poured into the top of the sinter and passed through the bed into the flask. _ π· Recovery of ethanol and continuous pouring through the bed for 28 minutes. Put the bed in the plus. ^ The soluble material is soluble in ethanol. 12. Next, ethanol and a second phospholipid extract were collected to obtain 1 〇 21 g of a phospholipid mixture described in Table 4 as an extract at 20 °C. 13 · Increase the temperature of the water bath to 3 ° ° C. 14. Measure 1 mL of fresh 95% ethanol and place in a water bath. 15. After the ethanol and the bed reached 30, the ethanol was poured into the top of the sinter and passed through the bed into the flask. Φ 16· Recovery of ethanol and continuous pouring through the bed for 30 minutes. In the bed, 3 (Γ(: soluble material) is dissolved in ethanol. 17. Then ethanol and the third phospholipid extract are collected to obtain a phospholipid mixture of 30 ° C extract described in Table 4 of 〇·97〇g. 18. Increase the temperature of the water bath to 50 ° C. 〇 19 · Measure 1 〇〇 mL of fresh 95% ethanol and place in a water bath. 20. After the ethanol and the bed reach 50t:, pour the ethanol into the sinter And flow through the bed into the flask. 21 • Recover ethanol and pour through the bed for 5 3 minutes. Dissolve the soluble material in the bed under 120 .. 120457.doc -30- 200808817. Ethanol and the fourth phospholipid extract were obtained as a mixture of phospholipids described in Table 4 as an extract of 50 ° C. 23. The temperature of the water bath was raised to 6 ° C. 24. One mL of fresh 95% ethanol was measured and placed. In a water bath. 2 5 · After ethanol and bed (4) c, pour ethanol into the top of the sinter and flow through the bed into the flask. 26. Recover ethanol and pour through the bed for 22 minutes. 〇. The soluble material in the underarm is dissolved in ethanol. 27. The ethanol and the fifth phospholipid extract are then collected to obtain 〇117 The fat-filled mixture of 6 0 C % is described in Table 4. 28. The residue of the collection bed was 1 277 g, which was found to contain a high content of 1 >8 and a neuroglycolipid. It is described as residual in Table 4. Table 4 shows the results obtained by this method. Table 4: Results obtained by the method of Example 3

原料流 產率(固體) 孔之% _%PLFeed stream yield (solid) % of pores _%PL

PC PI PS PE SM 1>HSM 4.4.8.520 1· 2 8 3 L o· 12 4 2 0 .818.5.53 441.0.35142. 2-751-7-8 390.0.26265. .95 5.2.31 f2.28308.PC PI PS PE SM 1>HSM 4.4.8.520 1· 2 8 3 L o· 12 4 2 0 .818.5.53 441.0.35142. 2-751-7-8 390.0.26265. .95 5.2.31 f2.28308 .

% PS % SM% PS % SM

5 .25 .2

27 50°C 60°C 萃取物 萃取物 10.5% 2.3% 73.0 64.4 12.3 4.6 11.1 24.1 4.7 17.1 48.2 43.4 17.7 8.1 4.5 1.9 3.5 11.0 16.2 6.4 120457.doc -31 - 200808817 可合併各步驟之萃取物或留作獨立磷脂部分。舉例而 言,2CTC及机萃取物為至少25%⑽產物,而其他萃取物 可用作PC/PE磷脂混合物。 實例1-3之討論 β實例[3中所用之方法為實驗室㈣。切估該等方法 疋否可大聽化以詩4設料,發明者考慮下列因 素。 原料流(饋入材料) 將二種不同原料流用於實例1中。 及原料流C因其在4Gt以上之溫度下為液體且因 此易力放於溶劑中而證明最易於使用。 〇:一方面,原料❹在0。。以上之溫度下為膠狀固體。在 以下硬且可使用低溫礙磨將原料流減小為精細 操作使得在萃取溶劑中充分分散。低溫礙磨以分 之需要使得原料流B成為所試驗之三種原料流 散料流’儘管如所述可藉由首先將該原料流分 放於少t溶劑中來克服此問題。 之::二=’目前相信"膠著,,係由未充分溶解㈣^ 之石件舳齙膽鹼(pc)導致。 料流讀原料流c之間,由於原料流A含有高得多 :二畴脂比例(意謂殘留物(使用3 〇:1之溶劑與原料流 θ 3有合理含量之PS(32.7% PS)及約6%之神經結膽 曰各里),因此原料流A較佳。因此,儘管使用 生之殘留物含有較高含量之碟脂,但許多健康應用需要產 120457.doc -32- 200808817 生富含PS及神經結醣脂之產物,使得原料流a成為兩者中 之較佳原料流。 另外’來自原料流A之副產物(”萃取物")(使用3〇:丄之溶 劑與原料流比產生)含有10.2%譲。然而,此產物亦富含 中性月曰貝且僅合有37.5%磷脂。可使用超臨界c〇2、脫膠或 丙酮進一步處理產物以移除中性脂質。27 50°C 60°C Extract Extract 10.5% 2.3% 73.0 64.4 12.3 4.6 11.1 24.1 4.7 17.1 48.2 43.4 17.7 8.1 4.5 1.9 3.5 11.0 16.2 6.4 120457.doc -31 - 200808817 The extracts from each step can be combined or kept Independent phospholipid fraction. For example, 2CTC and machine extract are at least 25% (10) product, while other extracts can be used as a PC/PE phospholipid mixture. Discussion of Examples 1-3 The method used in the example [3] is the laboratory (4). It is estimated that these methods can be used to designate the materials in the poem 4, and the inventors consider the following factors. Feed Stream (Feed Material) Two different feed streams were used in Example 1. And the feed stream C proves to be the easiest to use because it is liquid at temperatures above 4 Gt and is therefore easily placed in a solvent. 〇: On the one hand, the raw material is at 0. . The above temperature is a gelatinous solid. The following is hard and can be used to reduce the feed stream to a fine operation using a low temperature barrier to allow sufficient dispersion in the extraction solvent. The low temperature impediments require the feed stream B to be the three raw material stream streams tested' although this problem can be overcome by first dissolving the feed stream in less t solvent as described. :: === Currently believes that "glue, is caused by the incompletely dissolved (four)^ stone choline (pc). The stream read between the feed streams c, because the feed stream A contains a much higher: dinuclear fat ratio (meaning residue (using 3 〇:1 solvent and raw material flow θ 3 with a reasonable amount of PS (32.7% PS) And about 6% of the nerve knots, so the feed stream A is better. Therefore, although the use of raw residues contains a higher content of disc fat, many health applications need to produce 120457.doc -32- 200808817 Rich in PS and ganglioside products, making feed stream a the preferred feed stream for both. Also 'by-product from feed stream A ("extract" ") (using 3〇: 溶剂 solvent and The feed stream ratio yields 10.2% hydrazine. However, this product is also rich in neutral mussels and only contains 37.5% phospholipids. The product can be further treated with supercritical c〇2, degummed or acetone to remove neutral lipids. .

如已討論,藉由萃取原料流c所產生之殘留物產生朽之 最高富集(73.7%) ’但此產物之祌經結醣脂含量低於由原 料流A及原料流B所產生之殘留&之神經結耱脂含量。原 料流C比原料流A含有較少雜f。此情況突出降低上述原 料流之乳糖及灰分含量將對可獲得之?8萃取物之純度產生 極正面的影響。 最後’儘管原料流B為最不合需要之原料流,但由於其 膠狀性質’殘留物與使用原料流A萃取所得之殘留物類 似,具有類似含量之PS(23〇%)及神經結醣脂A㈣。副產 物(”萃取物”)由於含有極低含量之中性脂質、高含量之磷 脂(63·7〇/ο)且具有14.1% SM而更引人注意。 作為副產物(”萃取物II)結束 雖然原料流Α為實例丨所述方法之較佳原料流,但由於 之總原料流固體轉化為富含ps之產物,故產率存在 題。輯況意謂該方法之生產量低,且91%之原料流固 然而,原料流C之萃取產率甚至更低:6%之原料流固體 轉化成PS。然而,Ps產物之純度極高。 多步驟方法之產物(實例2) 120457.doc -33- 200808817 多可獨立保存之副 實例2與實例1之不同之處在於產生許 產物Γ萃取物”)。 、=表3中所概括,萃取可產生至多四種副產物,最引人 注意者為31% SM產物(萃取物3)。 填料床萃取(實例3) 技術最引人主思之恶樣很可能為在萃取期間進行之分As discussed, the residue produced by the extraction of feed stream c produces the highest enrichment (73.7%) 'but the saccharide content of this product is lower than the residue produced by feed stream A and feed stream B. & nerve knot rouge content. Raw stream C contains less impurities f than feed stream A. In this case, it is possible to reduce the lactose and ash content of the above raw materials. 8 The purity of the extract produces a very positive effect. Finally, although raw material stream B is the most undesirable raw material stream, its residue is similar to the residue obtained by extraction with feed stream A, with a similar content of PS (23%) and nerve glycolipids. A (four). By-products ("extracts") are more noticeable because they contain very low levels of neutral lipids, high levels of phospholipids (63.7%) and 14.1% SM. As a by-product ("Extract II"), although the raw material flowing is the preferred raw material stream of the method described in the above, since the total raw material stream solid is converted into a product rich in ps, the yield has a problem. The production of this method is low, and 91% of the feedstock is solid. However, the extraction yield of feed stream C is even lower: 6% of the feed stream solids are converted to PS. However, the purity of the Ps product is extremely high. Product (Example 2) 120457.doc -33- 200808817 The second example, which can be independently preserved, differs from Example 1 in that it produces a product Γ extract "). As summarized in Table 3, the extraction produced up to four by-products, the most noticeable being the 31% SM product (Extract 3). Packed bed extraction (Example 3) The most intriguing aspect of the technology is likely to be during the extraction process.

顧°顚然’藉由在步财特定操縱乙醇溫度亦可產含 SM之產物。 田 /方法完全將原料流3分館成含有高神經鞘翁及鱗脂 酿綠胺酸之部分。 然而,此選擇之一缺點在於如所述難以處理原料流B。 溶劑:原料流比 、亦發現溶劑與原料比直接影響不溶性部分中之PS濃度。 =用規律為·〉谷劑比率越高,不溶性部分中%純度就越 舉例而5,在實例1中發現溶劑與原料流Α之比率為30:1 時得到32.7%, PS部分。杏你_ , I刀 田使用5〇: 1之溶劑與原料比時,部 分為 38.9% PS。 # 、而3〇·1之〉谷劑比亦具有優點。此較低溶劑比在全規 ^下允許叙小之萃取容器,因此將最小化成本且改良生產 〇 溫度及時間 時間:溫度亦影響殘留物中之Ps純度。 等义數對王規杈運作均具有明顯之實際限制。推薦對 120457.doc -34- 200808817 於在最終產物中獲得合理含量之ps所需之持續時間而言’ 使溫度在經濟上及實務上盡可能地高。 此處發明者關注含有至少3〇% ps之產物。在此項研究 中,實例1之方法中原料流A及原料流c均得到超過3〇% ^ 目標之產物。 實例4 :水含量對乳品脂質萃取物(原料流句之乙醇分餾 (ethanol fraetiojjadojj)之影響Gu ° 顚然' can also produce SM-containing products by specifically manipulating the ethanol temperature in the step. The field/method completely divides the raw material stream 3 into a part containing high-stem sphingosine and squama. However, one of the disadvantages of this option is that it is difficult to process the feed stream B as described. Solvent: raw material flow ratio, and solvent to raw material ratio was also found to directly affect the PS concentration in the insoluble portion. = The rule is that the higher the ratio of the granules, the more the % purity in the insoluble fraction is. For example, in Example 1, it was found that the ratio of solvent to raw mash was 30:1, which gave 32.7%, PS fraction. Apricot you _ , I knife The field uses 5 〇: 1 solvent to raw material ratio, the part is 38.9% PS. # 、和3〇·1 〉Valley ratio also has advantages. This lower solvent ratio allows for smaller extraction vessels under full conditions, thus minimizing costs and improving production. Temperature and time: Temperature also affects Ps purity in the residue. The equivalent number has obvious practical limits on the operation of the king's rules. It is recommended to make the temperature as high as economically and practically as possible for the duration required to obtain a reasonable amount of ps in the final product. The inventors here focus on products containing at least 3% ps. In this study, both the feed stream A and the feed stream c in the method of Example 1 gave a product of more than 3% by weight. Example 4: Effect of water content on dairy lipid extract (ethanol fraetiojjadojj)

本實例展示在65°C下水含量對PS富集之影響。 在4〇 ml 95%乙醇(0%至4〇%水)中混合〇 8 g乳品脂質萃 取物(原料流B)。接著迅速將混合物加熱至65。〇且強烈震 盪。在週期性震盪下將樣品在65〇c下保持3小時。接著過 濾樣品且風乾固體,繼而在真空下乾燥。由up nmr分桁 樣品。結果展示於表$中。 在較低水含量下,與其他磷脂相比PS相對純度高,”之 回收率良好且部分易於處理成粉末。隨著水含量升高,Μ 回收率降低’產物中PC^SM含量升高且產生含有較多水 及氫化鱗脂之部分。 表5This example demonstrates the effect of water content on PS enrichment at 65 °C. 8 g of dairy lipid extract (feedstream B) was mixed in 4 ml of 95% ethanol (0% to 4% water). The mixture was then quickly heated to 65. It is also strong and turbulent. The sample was held at 65 ° C for 3 hours under periodic shaking. The sample was then filtered and the solid was air dried and then dried under vacuum. The sample is branched by up nmr. The results are shown in the table $. At lower water contents, the relative purity of PS is higher than that of other phospholipids, "the recovery rate is good and some are easy to process into powder. As the water content increases, the recovery of hydrazine decreases" and the PCTM content in the product increases. Produces a fraction containing more water and hydrogenated scales. Table 5

120457.doc -35 - 200808817 實’例5 :樣品與,溶劑比對乳品脂質萃取物(原料流…之乙醇 分餾之影響 本貫例展不在65t下樣品與溶劑比對PS富集之影響。 將2 g礼品脂質萃取物(原料流B)添加至2〇㈤丨%%乙醇中 且在65 C下混合。添加冷乙醇以獲得所需之樣品與溶劑 比’繼而混合。在冷藏器中歷時1小時之後,再次混合樣 品,接著加熱至65°C且再混合。將樣品在65它下靜置隔 仪’接著混合且過濾。所有混合均係使用…加比汀以進 行。在真空下乾燥所收集之固體且由3〗p NMR分析。結果 展示於下表6中。藉由增加溶劑之量來改良pS富集。在 1:1 〇〇之樣品·溶劑比下,不溶性材料中74·3%之磷脂為 PS。當磷脂佔此部分之56·6%時,Ps在此樣品中之量為 42%。 表6 樣品:溶劑 產率(固體%) % PL 4 1脂組成(%) PC PI PS PE CM 原料 23.9 7.9 11.3 Jl MZj 33 1 O丄Vx 99 ? 1:10 35 56.9 9.8 15.3 24.2 mJ . X 35.9 11.6 1:20 21 55.7 3.6 20.9 35.9 32.0 4.7 1:50 17 56.1 1.8 12.7 67.0 13.5 1 5 1:10» 15.4 56.6 1.2 10.2 74.3 8.7 1.0 實例6 ·· PH值對乳品脂質萃取物(原料流B)之乙醇分餾之 影響τ 本實例展示在65°C下pH值對PS富集之影響。 在65 C下將乳品脂質萃取物(0.8 g)(原料流B)添加至4〇 ml 95%乙醇中。乙醇含有5%水、5%冰乙酸或5%氨水 120457.doc -36- 200808817 (2·5%) ’且三種混合物之PH值分別為7.7、3.2及Η) 〇。藉 由經2小時週期性震_拌混合物,接著過濾'。在直空曰 下乾㈣分且由"Ρ NMR分析。結果展示於下表7中。酸性 條件^致取佳之1>8富集,但在寬阳值範圍内結果類似。 表7 --------- 原料 '產率 (固體%) %PL 磷脂組成(%) ^ PC 23.9 PI 一丨·~一 圓_ 7.9 PS 11.3 PE 33.1 SM —--- 29 ? pH值=3.2固體 24 59.7 3.5 23.3 44.5 23.8 X Λ pH值=7.7固體 31 46.8 5.5 16.3 42.1 28.9 Ο Λ3 5 0 pH值=10.0固體 33 52.0 4.8 17.7 393 31.4 山U 5.0 實例7 :溶劑對乳品脂質萃取物(原料流c)之分餾'之影響; 本實例展示醇鏈長對PS富集之影響。 在攪拌式加熱板上將100 g具有5%水之溶劑加熱至 65°C (由於曱醇沸點較低,對於甲醇而言為5〇t:)。達到溫 度之後,添加2 g乳品脂質萃取物(原料流c)且混合2小時。 將樣品自加熱下移除且趁熱在真空下過濾。接著在 Whatman 4濾紙上乾燥不溶性部分且旋轉蒸發可溶性部 分。記錄所有重量以進行質S平衡。由3NMR分析樣 品。結果展示於表8中。 120457.doc 37- 200808817 表8 產率 (固體%) % PL ~~脂組成 PC PI PS CM 原料 41.7 26.9 6.8 10.4 X Kj OitX 99 Q 曱醇 不溶性 可溶性 42 • 53 13·1 56.6 0.9 31.3 11.2 6.4 64.7 14 *^1.0 21.7 1 1.3 07 c 乙醇 不溶性 可溶性 7 93 89.3 41.2 0.8 29.6 7.8 6.4 82.5 1? 6.0 5? Z l .Z> N/D 0〇 A 正丙醇 不溶性 可溶性 3 96 75.2 36.8 0.5 31.5 6.6 4.3 8g.〇 3.6 3Z.O 2.6 33 6 N/D 96 ? 異丙醇 不溶性 可溶性 6 93 86.6 0.7 11.0 80.5 m\J 4.6 0.6 實例8 :各種來源之磷脂之乙醇分餾(樣品比溶劑ι:ι〇) 本實例展示本發明之方法可廣泛用於使用1:1〇之樣品與 >谷劑比及50°C之溫度的多種脂質基質。本實例亦展示心磷 脂當存在於饋入材料中時由本發明之方法實質上濃縮。 將下列來源之畜含石粦脂之萃取物(Q . 5 g ): •牛肝, •牛心, •鯊魚脊髓, •知樣魚(lemon JTish),及 •新西蘭無鬚鳕頭(hoki head) 稱重於試管中且添加5 g 95%乙醇。塞緊試管且伴隨週 期性震盪及2小時之超音波處理置於5〇χ水浴中。移除$ 吕且離心(3000 rpm,2 min)並將上清液自固體傾析。在氬 120457.doc -38- 200808817 氣流下且接著在真空下自部分移除溶劑。由Mp NMR测定 磷脂概況。結果展示於表9中。 在所有情況下,不溶性部分中均富含所需之磷脂PS及 CL。鱗脂(尤其是來自檸檬魚之磷脂)比乳品脂質具有較高 含量之多元不飽和脂肪酸,該等脂肪酸增大磷脂在乙醇中 之溶解度。可溶性部分中富含SM。 表9 產率 (固體%) % PL 磷脂組成(%) PC PI PS PE SM CL 牛肝 原料 56.7 44.9 10.4 2.2 23.0 3.6 8.3 不溶性 12 73.0 9.1 29.1 6.2 33.8 N/D 16.0 可溶性 __ 88 43.2 56.9 3.8 0.9 20.7 4.3 6.1 牛心 原料 61.1 21.7 4.4 2.0 20.8 5.4 26.4 不溶性 27 72.9 4.4 14.0 5.1 21.6 6.6 41.1 可溶性 73 55.4 34.9 1.0 0.5 25.5 6.6 15.8 鯊魚脊髓 原料 22.9 35.7 1.4 12.6 47.5 2.8 N/D 不溶性 22 43.5 21.3 2.7 23.4 46.8 3.9 N/D 檸檬魚 原料 63.7 46.2 7.9 3.5 25.0 5.2 7.9 不溶性 26 76.1 8.3 27.6 10.7 29.4 N/D 19.6 可溶性 74 50.5 58.7 2.0 1.3 24.6 5.8 4.2 新西籣無鬚鱈頭 原料 33.2 49,6 5.3 6.3 22.8 3.1 不溶性 23 26.1 25.6 10.2 13.4 22.1 10.6 可溶性 77 36.2 52.2 4.5 5.4 24.5 2.9120457.doc -35 - 200808817 实例例5: Sample and solvent ratios of dairy lipid extracts (the effect of ethanol fractionation on the feed stream... The actual example is not the effect of sample-to-solvent ratio on PS enrichment at 65t. 2 g of the gifted lipid extract (feedstream B) was added to 2 〇 (5) 丨 % % ethanol and mixed at 65 C. Cold ethanol was added to obtain the desired sample to solvent ratio 'and then mixed. In the refrigerator for 1 After an hour, the samples were again mixed, then heated to 65 ° C and re-mixed. The sample was allowed to stand underneath 65. Then mixed and filtered. All mixing was carried out using ... Gabitin. Drying under vacuum The collected solids were analyzed by 3 spectroscopy. The results are shown in the following Table 6. The pS enrichment was improved by increasing the amount of solvent. 74.3 in the insoluble material at a sample to solvent ratio of 1:1 〇〇 The % phospholipid is PS. When phospholipids account for 56.6% of this fraction, the amount of Ps in this sample is 42%. Table 6 Sample: Solvent yield (% solids) % PL 4 1 Lip composition (%) PC PI PS PE CM Material 23.9 7.9 11.3 Jl MZj 33 1 O丄Vx 99 ? 1:10 35 56.9 9.8 15.3 24.2 mJ . X 35.9 11.6 1:20 21 55.7 3.6 20.9 35.9 32.0 4.7 1:50 17 56.1 1.8 12.7 67.0 13.5 1 5 1:10» 15.4 56.6 1.2 10.2 74.3 8.7 1.0 Example 6 ·· PH value for dairy lipid extract (raw material Effect of Ethanol Fractionation of Stream B) τ This example shows the effect of pH on PS enrichment at 65 ° C. Add dairy lipid extract (0.8 g) (feed stream B) to 4 〇 ml at 65 C In ethanol, ethanol contains 5% water, 5% glacial acetic acid or 5% ammonia water 120457.doc -36-200808817 (2.5%) and the pH values of the three mixtures are 7.7, 3.2 and Η, respectively. The mixture was mixed by a periodic shaking for 2 hours, followed by filtration. Dry (4) in a straight space and analyzed by "Ρ NMR. The results are shown in Table 7 below. The acidic conditions gave a good 1 > 8 enrichment, but the results were similar in the broad Yang range. Table 7 --------- Raw material 'yield (solid %) % PL Phospholipid composition (%) ^ PC 23.9 PI 丨·~一圆 _ 7.9 PS 11.3 PE 33.1 SM —--- 29 ? pH value =3.2 solid 24 59.7 3.5 23.3 44.5 23.8 X Λ pH = 7.7 solid 31 46.8 5.5 16.3 42.1 28.9 Ο Λ 3 5 0 pH = 10.0 solid 33 52.0 4.8 17.7 393 31.4 Mountain U 5.0 Example 7: Solvent on dairy lipid extract ( Effect of fractionation of feed stream c); This example demonstrates the effect of alcohol chain length on PS enrichment. 100 g of a solvent with 5% water was heated to 65 ° C on a stirred hot plate (since the lower boiling point of sterol, 5 〇 t for methanol). After reaching the temperature, 2 g of the dairy lipid extract (feed stream c) was added and mixed for 2 hours. The sample was removed from the heat and filtered under vacuum. The insoluble fraction was then dried on Whatman 4 filter paper and the soluble fraction was rotary evaporated. Record all weights for mass S balance. The sample was analyzed by 3 NMR. The results are shown in Table 8. 120457.doc 37- 200808817 Table 8 Yield (% solids) % PL ~~ Lipid composition PC PI PS CM Material 41.7 26.9 6.8 10.4 X Kj OitX 99 Q Sterol insoluble soluble 42 • 53 13·1 56.6 0.9 31.3 11.2 6.4 64.7 14 *^1.0 21.7 1 1.3 07 c Ethanol insoluble soluble 7 93 89.3 41.2 0.8 29.6 7.8 6.4 82.5 1? 6.0 5? Z l .Z> N/D 0〇A n-propanol insoluble soluble 3 96 75.2 36.8 0.5 31.5 6.6 4.3 8g.〇3.6 3Z.O 2.6 33 6 N/D 96 ? Isopropanol insoluble soluble 6 93 86.6 0.7 11.0 80.5 m\J 4.6 0.6 Example 8: Ethanol fractionation of phospholipids from various sources (sample ratio solvent ι: ι〇) This example demonstrates that the method of the present invention is widely applicable to a variety of lipid matrices using a sample of 1:1 Torr with a > trough ratio and a temperature of 50 °C. This example also shows that the phospholipid is substantially concentrated by the method of the invention when present in the feed material. Extracts from the following sources of animal extracts (Q. 5 g): • Bovine liver, • Bull heart, • Shark spinal cord, • Lemma JTish, and • New Zealand hoki head Weigh in a test tube and add 5 g of 95% ethanol. The tube was stoppered and placed in a 5 〇χ water bath with periodic shaking and 2 hours of ultrasonic treatment. The $ ί was removed and centrifuged (3000 rpm, 2 min) and the supernatant was decanted from the solid. The solvent was partially removed under a stream of argon 120457.doc -38 - 200808817 and then under vacuum. The phospholipid profile was determined by Mp NMR. The results are shown in Table 9. In all cases, the insoluble fraction is enriched with the desired phospholipids PS and CL. Scale fats (especially phospholipids from lemonfish) have a higher content of polyunsaturated fatty acids than dairy lipids, which increase the solubility of phospholipids in ethanol. The soluble fraction is rich in SM. Table 9 Yield (% solids) % PL Phospholipid composition (%) PC PI PS PE SM CL Bovine liver raw material 56.7 44.9 10.4 2.2 23.0 3.6 8.3 Insoluble 12 73.0 9.1 29.1 6.2 33.8 N/D 16.0 Solubility __ 88 43.2 56.9 3.8 0.9 20.7 4.3 6.1 Beef heart material 61.1 21.7 4.4 2.0 20.8 5.4 26.4 Insoluble 27 72.9 4.4 14.0 5.1 21.6 6.6 41.1 Solubility 73 55.4 34.9 1.0 0.5 25.5 6.6 15.8 Shark spinal cord material 22.9 35.7 1.4 12.6 47.5 2.8 N/D insoluble 22 43.5 21.3 2.7 23.4 46.8 3.9 N/D Lemonfish raw material 63.7 46.2 7.9 3.5 25.0 5.2 7.9 Insoluble 26 76.1 8.3 27.6 10.7 29.4 N/D 19.6 Solubility 74 50.5 58.7 2.0 1.3 24.6 5.8 4.2 New Zealand sorghum without raw material 33.2 49,6 5.3 6.3 22.8 3.1 Insoluble 23 26.1 25.6 10.2 13.4 22.1 10.6 Soluble 77 36.2 52.2 4.5 5.4 24.5 2.9

由於分析期間之差解析度,已將新西蘭無鬚鱈頭PE及 SM濃度集中在一起。 實例9 :各種來源之磷脂之乙醇分餾,(樣品比溶,劑υ〇) 120457.doc -39- 200808817 本實例展示可自低PS含量之饋入材料富集PS。 在攪拌式加熱板上將100 g 95%乙醇加熱至65°c。達到 溫度之後,添加2 g樣品且混合2小時。將樣品自加熱下移 除且趁熱在真空下過濾。在Whatman 4濾紙上截獲且接著 乾燥不溶性部分且旋轉蒸發可溶性部分以使體積降低。記 錄所有重量以進行質量平衡。由31P NMR分析樣品。結果 展示於表1 0中。 表10New Zealand's unneeded PE and SM concentrations have been brought together due to the difference in resolution during the analysis. Example 9: Ethanol fractionation of phospholipids from various sources, (sample ratio, reagent enthalpy) 120457.doc -39- 200808817 This example demonstrates the enrichment of PS from feedstock materials with low PS content. 100 g of 95% ethanol was heated to 65 ° C on a stir plate. After reaching the temperature, 2 g of sample was added and mixed for 2 hours. The sample was removed from the heat and filtered under vacuum. The insoluble fraction was intercepted on Whatman 4 filter paper and then the insoluble fraction was dried and the soluble fraction was rotary evaporated to reduce the volume. Record all weights for mass balance. The sample was analyzed by 31P NMR. The results are shown in Table 10. Table 10

產率 (固體%) % PL 磷脂組成(%) PC PI PS PE SM CL 大豆卵磷脂 原料 66.3 33.5 19.8 N/D 29.1 N/D N/D 不溶性 24 69.0 6.4 39.4 Li 29.1 N/D N/D 可溶性 76 73.2 53.0 7.7 N/D 21.8 N/D N/D 蛋 原料 27.7 70.2 1.8 1.6 18.8 4.7 N/D 不溶性 4 29.1 8.4 14.7 48.4 18.0 N/D N/D 可溶性 96 30.3 71.0 1.8 N/D 18.0 4.4 N/D 工業應用 本發明可用於提供具有高含量之特定磷脂/鞘脂(包括磷 脂醯絲胺酸、神經結醣脂及神經鞘磷脂)之產物。此等產 物可用於許多應用中,包括嬰兒配方奶粉、大腦健康、運 動營養、藥物傳遞、皮膚科應用及關節炎。 參考文獻Yield (% solids) % PL Phospholipid composition (%) PC PI PS PE SM CL Soy lecithin material 66.3 33.5 19.8 N/D 29.1 N/DN/D Insoluble 24 69.0 6.4 39.4 Li 29.1 N/DN/D Soluble 76 73.2 53.0 7.7 N/D 21.8 N/DN/D Egg material 27.7 70.2 1.8 1.6 18.8 4.7 N/D insoluble 4 29.1 8.4 14.7 48.4 18.0 N/DN/D Solubility 96 30.3 71.0 1.8 N/D 18.0 4.4 N/D Industrial application The invention can be used to provide products having high levels of specific phospholipids/sphingolipids, including phospholipids, riboskinates, and sphingomyelins. These products can be used in many applications, including infant formula, brain health, sports nutrition, drug delivery, dermatological applications, and arthritis. references

Jensen, R.G. 2002. The Composition of Bovine Milk Lipids: January 1996 to December 2000. J. Dairy Sci. 85: 120457.doc -40- 200808817 295-350Jensen, R.G. 2002. The Composition of Bovine Milk Lipids: January 1996 to December 2000. J. Dairy Sci. 85: 120457.doc -40- 200808817 295-350

Ladisch, S.; Gillard, B. 1985. A solvent partition method for microscale ganglioside purification. Anal. Biochem. 146: 220-231Ladisch, S.; Gillard, B. 1985. A solvent partition method for microscale ganglioside purification. Anal. Biochem. 146: 220-231

Padley F.B.; Gunstone, F.D.; Harwood^ J.L. 1986. Occurrence and characteristics of oils and fats ,在"TfiePadley F.B.; Gunstone, F.D.; Harwood^ J.L. 1986. Occurrence and characteristics of oils and fats, at "Tfie

Lipid Handbook (Gunstone,F.D.; Harwood, J.L.; Padley, F.B·編)中第 49 -1 70 頁.Chapman and Hall,London-NY oLipid Handbook (Gunstone, F.D.; Harwood, J.L.; Padley, F.B.), pp. 49 -1 70. Chapman and Hall, London-NY o

Wu? Y“ Wang,T· 2004. Fractionation of crude soybean lecithin with aqueous ethanol. JAOCS 81(7): 697-704 〇 120457.doc -41 -Wu? Y" Wang, T. 2004. Fractionation of crude soybean lecithin with aqueous ethanol. JAOCS 81(7): 697-704 〇 120457.doc -41 -

Claims (1)

200808817 十、申請專利範圍: 1. 一種將饋入材料分餾成可溶性成份及不溶性成份之方 法’其包含: (a)提供包含下列各物中之一或多者之饋入材料: (0至少1%重量/重量之磷脂醯絲胺酸; (ii) 至少1%重量/重量之神經鞘鱗脂; (iii) 至少1%重量/重量之心磷脂;或 (π)至少〇·3%重量/重量之神經結醣脂 (gangliosides); ()提七、包合一或多種C1-C3 一元醇及水之溶劑,其中 忒一或多種醇之水含量為〇至4〇%體積/體積; (c)=该饋入材料與該溶劑接觸且隨後將含有該等可 溶性成份之溶劑與該等不溶性成份分離; ⑷視情況分離該等可溶性成份及該溶劑。 2. 如請求項1 $太、、土 、 '八中该饋入材料包含少於10%之蛋白 及少於10%之乳糖。 贪曰 /、中 >、於1 〇%之該饋入材料包含蛋 ’其令該饋入材料包含大於1%之磷 〃中邊饋入材料包含大於2%之石粦月 其中該饋入材料包含大於5%之磷脂 3·如請求項1之方法 及乳糖。 4·如請求項〗之方法 &絲胺酸。 5.如請求項〗之方法 醯絲胺酸。 6·如請求項1之方法 醯絲胺酸。 120457.doc 200808817 才才料包含大於1 %之神經 7 · 如請求項1夕·土 # 、方法,其中該饋入 鞘鱗脂。 8. 如請求項 1之方法, 鞘磷脂。 9. 如請求項 1之方法, 鞘磷脂。 10. .如請求項 1之方法, 脂。 11· 如請求項1之方法, 脂。 12. 如請求項 1之方法, 脂。 13. 如請求項 1之方法, 經結_脂 0 14. 如請求j胃 1之方法, 結醣脂。 15. 如請求項 1之方法, 結St月旨D 16. 如請求項 1至15中任 經 經 材料包含大於15%之神 1 %之心石粦 法’其中該饋入材料包含大於5%之, 法其中该饋入材料包含大於〇·3%之神 經 經 自陸地氣⑻^ 〗之方法,#中該饋人材料係源 萍類、S/ 動物、陸地植物、海洋植物或諸如微 、酵母及細菌之微生物。 17·如請求項16之方法,苴 、, ,、甲°亥饋入材料係源自綿羊、I 手、豬、小鼠、水牛、略酽、巷Α 山 φ , 午H、犛牛、馬、驢、美洲駝、 牛或人類。 ^ 120457.doc 200808817 18.如明求項丨6或丨7之方法,其中該饋入材料係選自:組 織、組織部分、器官、器官部分、奶、奶部分、初乳、、 初乳部分、血液及血液部分。 19·如明求項16之方法,其中該饋入材料係源自乳品材料、 大显材料、蛋、動物組織、動物器官或動物血液。 20·如明求項ι 6之方法,其中該饋入材料係選自:包含乳品 脂質之組合物、包含蛋脂質之組合物及包含海洋生物脂 質之組合物〇200808817 X. Patent Application Range: 1. A method for fractionating a feed material into a soluble component and an insoluble component, which comprises: (a) providing a feed material comprising one or more of the following: (0 at least 1 % weight/weight of phospholipid lysine; (ii) at least 1% w/w of sphingolipid; (iii) at least 1% w/w of cardiolipin; or (π) at least 3%·3% by weight/ Weight gangliosides; () seven, a solvent containing one or more C1-C3 monohydric alcohols and water, wherein the water content of the one or more alcohols is from 〇 to 4% by volume/volume; c) = the feed material is contacted with the solvent and then the solvent containing the soluble components is separated from the insoluble components; (4) separating the soluble components and the solvent as appropriate. 2. If the claim 1 is too, Soil, 'eight in the feed material contains less than 10% protein and less than 10% lactose. Greed /, medium >, at 1%% of the feed material contains the egg 'which makes the feed material The feed material containing more than 1% of the phosphonium contains more than 2% of the sarcophagus, wherein the feed material Containing more than 5% of phospholipids 3. The method of claim 1 and lactose. 4. The method of claim & serine. 5. The method of claim 醯 胺 胺. Method 醯 胺 胺 120 120 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 Sphingomyelin. 9. The method of claim 1, sphingomyelin 10. The method of claim 1, lipid 11. The method of claim 1, lipid 12. The method of claim 1, lipid. If the method of claim 1 is followed by the method of lipolysis, 14. If the method of j stomach 1 is requested, the glycolipid is obtained. 15. If the method of claim 1 is used, the conclusion is as follows: 16. In claims 1 to 15, Any material containing more than 15% of the gods 1% of the heart stone method 'where the feed material contains more than 5%, the method wherein the feed material contains more than 3% · 3% of the nerve from the land gas (8) ^ 〗 In the method, the material in the source is source, S/ animal, land plant, marine plant or Microorganisms such as micro, yeast and bacteria. 17. The method of claim 16, 苴,, ,,甲甲, into the material is derived from sheep, I hands, pigs, mice, buffalo, slightly squat, alley φ , 午H, yak, horse, donkey, llama, cow or human. ^ 120457.doc 200808817 18. The method of claim 6 or 丨7, wherein the feed material is selected from: tissue, tissue part , organs, organs, milk, milk, colostrum, colostrum, blood and blood. The method of claim 16, wherein the feed material is derived from dairy material, macroscopic material, egg, animal tissue, animal organ or animal blood. 20. The method of claim 6, wherein the feed material is selected from the group consisting of a composition comprising a dairy lipid, a composition comprising an egg lipid, and a composition comprising a marine biolipid. 21.如請求項1至20中任—項之方法,其中該饋入材料為牛 奶部分。 22·如請求項21之方法,其中該饋入材料係選自:白脫奶 (buttermilk)、白脫奶部分、β乳清、爲乳清部分、白脫乳 清、白脫乳清部分、乳清、乳清部分、初乳及初乳部 分。 23.如請求項丄至以中任一項之方法,其中該饋入材料包含 乳脂球膜。 2 4.如請求項i至2 3中任一項之方法,其中該饋入材料已經 基因修飾。 25·如請求項丨至2钟任—項之方法,其中該饋人材料為固 體形式。 26. 如請求項25之方法,其中該饋入材料在與該溶劑接觸之 前經低溫碾磨。 27. 如請求項丨至26中任—項之方法,其中該饋人材料在與 該溶劑接觸之前經低溫碾磨,以獲得〇1_5 mm之平均粒 120457.doc 200808817 度。 28·如請求項!至27中任一項 廿山斗 貝I万去,其中該溶劑包含: (a) 選自下列各物之醇: T知、乙醇、正丙醇、異丙 醇及其混合物;及 (b) 0-40%體積/體積之水σ 29·如請求項28之方法,直 劑包含介於0與⑽^义體積/ 體積之間的水。 3 0 ·如明求項2 8之方法,立中兮汾 雕 /、 Μ办诏匕έ,丨於1與10%體積/ 肢積之間的、水。 31·如請求項28至30中任一項之方 法,其中該醇為乙醇。 32·如凊求項i至3 !中任一 、方法,其中該溶劑包含95%之 乙醇水溶液。 3 3 ·如請求項!至3 2申任一 項之方法,其中溶劑盥饋入Μ料 之比率介於㈣與⑽」之間。 I、饋入材枓 月求項3 3之方法,其中該《㈣^ ^ ^ ^ 20:1與60:1之間。 I、饋入材枓之比率介於 35.如請求項33之方法,其决 25:1與4〇α之間。 竹Τ+之比率介於 36·如請求項^至^中任—之 3〇°C下進行。 、z ,其中該方法係在高於 37·如請求項36之方法,其 认如請求項36之方法,其二方=在高於5(rc下進行。 队如請求項!^中任_項之Λ方法糸在兩於饥下進行。 降低或升高溫度之步驟進行。’其中該方法係以許多 120457.doc 200808817 40.如請求項+ 、 、 心中任一項之方法,其中該方法係在低於 或等於4。(:下進行。 41 ·如請求.項4 〇 > 士 π 、之方法,其中該方法係在低於或等於0。(:下進 行。 42 ·如請求項1至4 1 φ /工 s >七、1 i中任一項之方法,其中步驟(c)係進行 小時之間043·如凊求項42之方法,其中步驟(c)係進行2小時。 44. 如請求項^至们中任一項之方法 材料係接觸一次。. 45. 如請求項中任一項之方法 材料係與同—批溶劑接觸多次。 46. 如請求項1至43中任一項之方法 一批以上之溶劑接觸。 47. 如請求項1至46中任一項之方法 斤机、、二之饋入材料填料床使該溶劑與該饋入 48·如請求項1至46中 之 十接觸 頁之方法,其中藉由攪拌來混 4 /谷劑及该饋入材科。 49=請求項48之方法,其中該擾拌係藉由高㈣混人 行。 口50· -種由如請求们至辦任—項之方法產生之產物。 5】·如請求㈣之產物’其中該產物為可溶性材料。 52.如請求項50之錢,其中該絲為不溶性材料。 53 ·如請求項5〇或5 1之產物,苴中 ,、T忒產物含有比該饋入 多的神經鞘磷脂。 材71 其中該溶劑與該饋力 其中該溶劑與該饋^ 其中該饋入材料係 其中猎由使用該溶 I20457.doc 200808817 54.如請求項50或51之產物,其中該產物包含大於3% 賴磷脂。 5 5.如請求項50或51之產物’其中該產物包含大於1〇%之神 經鞘磷脂。 56. 如請求項50或51之產物,其中該產物包含大於15%之神 經勒磷脂。 57. 如請求項50或52之產物,其中該產物含有比該饋入材料 多的磷脂醯絲胺酸。 5 8 ·如請求項50或52之產物,其中該產物包含大於5%之磷脂 醯絲胺酸。 5 9 ·如晴求項50或52之產物,其中該產物包含大於3 之碟 脂醯絲胺酸。 6〇·如請求項50或52之產物,其中該產物包含大於7〇%之碟 脂酿絲胺酸。 61·如請求項50或52之產物,其中該產物含有比該饋入材料 多的神經結醣脂。 62.如請求項50或52之產物,其中該產物包含大於2%之神經 結5¾脂。 63·如請求項5〇或52之產物,其中該產物包含大於4%之神經 結釀脂。 64. 如請求項5〇或52之產物,其中該產物包含大於6%之神經 結脂。 65. 如請求項5〇或52之產物,其中該產物含有比該饋入材料 多的心磷脂。 120457.doc 200808817 66. 如請求項50或52之產物,其中該產物包含大於5%之心磷 脂。 67. 如請求項50或52之產物,其中該產物包含大於10%之心 石粦脂。 68. 如請求項50或52之產物,其中該產物包含大於25%之心 磷脂。The method of any one of claims 1 to 20, wherein the feed material is a milk portion. The method of claim 21, wherein the feeding material is selected from the group consisting of: buttermilk, buttermilk fraction, beta whey, whey fraction, whey whey, whey whey fraction, Whey, whey, colostrum and colostrum. 23. The method of any one of the preceding claims, wherein the feed material comprises a milk fat globule film. The method of any one of claims 1 to 2, wherein the feed material has been genetically modified. 25. The method of claim 2 to 2, wherein the feed material is in solid form. 26. The method of claim 25, wherein the feed material is cryogenically milled prior to contact with the solvent. 27. The method of claim 26, wherein the feed material is milled at a low temperature prior to contact with the solvent to obtain an average particle size of 4571_5 mm 120457.doc 200808817 degrees. 28·If requested! To any of the 27 廿山斗贝 I, where the solvent comprises: (a) an alcohol selected from the group consisting of: T, ethanol, n-propanol, isopropanol, and mixtures thereof; and (b) 0 - 40% by volume/volume of water σ 29. The method of claim 28, wherein the direct agent comprises between 0 and (10)^ volume/volume. 3 0 ·If the method of the item 2 8 is made, the Lizhong 兮汾 / / Μ Μ, 丨 between 1 and 10% of the volume / limb product, water. The method of any one of claims 28 to 30, wherein the alcohol is ethanol. 32. The method according to any of the preceding claims, wherein the solvent comprises a 95% aqueous solution of ethanol. 3 3 · As requested! The method of any of the preceding claims, wherein the ratio of the solvent enthalpy feeding material is between (4) and (10)". I. Feeding material 枓 Monthly method 3 3, wherein the "(4) ^ ^ ^ ^ 20:1 and 60:1. I. The ratio of the feed material is between 35. According to the method of claim 33, it is between 25:1 and 4〇α. The ratio of bamboo rafts + is between 36 如 ° C as required in the request ^ to ^. , z, wherein the method is above 37. The method of claim 36, which is considered to be the method of claim 36, the two of which are performed above 5 (rc). The team is as requested! The method of 项 糸 is carried out under two hunger. The steps of lowering or raising the temperature are carried out. 'The method is based on a number of 120457.doc 200808817 40. The system is below or equal to 4. (: proceeding. 41 · as requested. Item 4 〇> π, the method, where the method is below or equal to 0. (: proceeding. 42 · as requested The method of any one of the above, wherein the step (c) is performed between 00 and 00, wherein the step (c) is performed for 2 hours. 44. If the method material of any one of the requirements is contacted once. 45. If the method of any of the claims is in contact with the same batch of solvent, multiple times. 46. The method of any one of the above-mentioned methods is in contact with a plurality of solvents. 47. The method according to any one of claims 1 to 46, wherein the feeding material is The packed bed is a method of contacting the solvent with the feed of 48. The contact page of the tenth of claims 1 to 46, wherein the mixture is mixed with the grain and the feed material by stirring. 49 = the method of claim 48, Wherein the scramble is made by high (four) mixed. Port 50 - a product produced by a method such as a request to an office - 5) - as requested in (4) of the product 'where the product is a soluble material. The money of claim 50, wherein the silk is an insoluble material. 53. The product of claim 5 or 51, the middle, and the T忒 product contain more sphingomyelin than the feed. With the feed force of the solvent with the feed ^ where the feed material is hunted by the use of the solution I20457.doc 200808817 54. The product of claim 50 or 51, wherein the product contains greater than 3% lysine. 5 5 The product of claim 50 or 51 wherein the product comprises greater than 1% sphingomyelin. 56. The product of claim 50 or 51, wherein the product comprises greater than 15% neurolephospholipid. The product of item 50 or 52, wherein the product contains more than the feed material The product of claim 50 or 52, wherein the product comprises greater than 5% phospholipid quinic acid. 5 9 · The product of 50 or 52, wherein the product comprises greater than 3的脂脂丝酸酸。 6. The product of claim 50 or 52, wherein the product comprises greater than 7% by weight of the fat-loading serine. 61. The product of claim 50 or 52, wherein The product contains more neuroglycolipid than the feed material. 62. The product of claim 50 or 52, wherein the product comprises greater than 2% of a nerve knot. 63. The product of claim 5 or 52, wherein the product comprises greater than 4% nerve knot fat. 64. The product of claim 5, or 52, wherein the product comprises greater than 6% of a neurolipid. 65. The product of claim 5, or 52, wherein the product contains more cardiolipin than the feed material. 120457.doc 200808817 66. The product of claim 50 or 52, wherein the product comprises greater than 5% cardiolipin. 67. The product of claim 50 or 52, wherein the product comprises greater than 10% heart stone rouge. 68. The product of claim 50 or 52, wherein the product comprises greater than 25% cardiolipin. 120457.doc 200808817 七、指定代表圖: (一) 本案指定代表圖為:(無) (二) 本代表爵之元件符號簡單說明: 八、本案若有化學式時,請揭示最能顯示發明特徵的化學式: • (無)120457.doc 200808817 VII. Designated representative map: (1) The representative representative of the case is: (none) (2) The symbolic symbol of the representative of the prince is simple: 8. If there is a chemical formula in this case, please reveal the best indication of the characteristics of the invention. Chemical formula: • (none) 120457.doc120457.doc
TW096114187A 2006-04-20 2007-04-20 Product and process TW200808817A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ54668206 2006-04-20

Publications (1)

Publication Number Publication Date
TW200808817A true TW200808817A (en) 2008-02-16

Family

ID=38625251

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096114187A TW200808817A (en) 2006-04-20 2007-04-20 Product and process

Country Status (2)

Country Link
TW (1) TW200808817A (en)
WO (1) WO2007123425A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3763219A1 (en) * 2007-10-19 2021-01-13 Fonterra Co-Operative Group Limited Methods of maintaining or increasing growth or cognitive development
AU2012346594B2 (en) * 2011-11-30 2017-12-21 Agency For Science, Technology And Research GM1 ganglioside to Annexin V microparticle polypeptide ratio for biological monitoring
WO2018109203A2 (en) * 2016-12-15 2018-06-21 Frieslandcampina Nederland B.V. Two-dimensional fractionation of milk fat
AU2019291666B2 (en) 2018-06-22 2023-09-21 Fonterra Co-Operative Group Limited Use of polar lipids to treat or prevent gestational diabetes mellitus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532141A (en) * 1995-06-13 1996-07-02 Holler; Larry D. Process for obtaining ganglioside lipids
JP4009066B2 (en) * 2001-02-15 2007-11-14 株式会社ヤクルト本社 Fractionation of phosphatidylserine
CA2507243A1 (en) * 2002-11-26 2004-06-10 Phares Pharmaceutical Research N.V. Marine lipid compositions
US20050170063A1 (en) * 2004-01-29 2005-08-04 Lalit Chordia Production of powder and viscous material

Also Published As

Publication number Publication date
WO2007123425A1 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
JP5727392B2 (en) Phosphatidylserine-enriched milk fraction for the production of functional foods
AU2007241642B2 (en) Process for separating lipid materials
Price et al. Extraction of phospholipids from a dairy by-product (whey protein phospholipid concentrate) using ethanol
EP1938695B1 (en) Powder being rich in milk-origin complex lipids
CN101484025A (en) Infant formulas for early brain development
TW200808817A (en) Product and process
Alhassani Camel milk: Nutritional composition, therapeutic properties, and benefits for human health
Oliveira et al. Composition, fractionation, techno-functional properties and applications of milk fat globule membrane–derived material
Elías‐Argote et al. Dairy ingredients containing milk fat globule membrane: description, composition, and industrial potential
Trziszka et al. Eggs as a very promising source of biomedical and nutraceutical preparations: a review
JP4559836B2 (en) Method for producing a complex lipid-rich material and a complex lipid-rich material
Nielsen Production of phospholipids from spray-dried egg yolk by consecutive in situ solid phase extraction with acetone and ethanol
Karrar et al. Analytical advances in the determinations of dietary sphingolipids in milk, dairy products, and infant formula and impacts on human health
Jiménez-Flores et al. Beverages based on milk fat globule membrane (MFGM) and other novel concepts for dairy-based functional beverages
JP5737778B2 (en) Extraction method of phospholipid and / or lysophospholipid
RU2325176C2 (en) Method of laminaria powder production with higher iodine content
CN116114756A (en) Method for separating MFGM from whole milk and application
Alonso López et al. Study on the effect of β-cyclodextrin on phospholipids and cholesterol of the milk fat globule membrane
EP2163160A1 (en) Composition richly containing polar lipid and method of manufacturing the same
Harford Selective removal of fat from acid whey during whey protein concentrate manufacture: a thesis presented in partial fulfilment of the requirements for the degree of Masters of Technology in Food Technology
WO2002015843A2 (en) Agent for regulating lipidic metabolism and method for producing said agent
NZ571454A (en) A process for supercritical extraction and separation of lipid materials